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use$of$ reperfusion$ therapy$by$primary$percutaneous$coronary$ intervention.$Despite$





where$ they$ contribute$ to$ the$ inflammatory$ milieu.$ While$ the$ function$ of$ classical$
monocytes$ in$ this$ response$has$ been$well$ described,$ the$ role$ of$ the$ non+classical$
monocyte$subset$is$poorly$defined.$These$cells$express$high$levels$of$the$fractalkine$









cells$ show$ an$ increased$ depletion$ in$ patients$ with$ larger$ infarcts$ and$ lower$ left$
ventricular$ ejection$ fraction,$ thereby$ acting$ as$ a$ potential$ prognostic$ biomarker$ of$
myocardial$outcome.$In$complementary$pre+clinical$mouse$studies$of$cardiac$I/R,$this$





not$ significantly$ affected$ by$ loss$ of$ the$Cx3cr1$ gene.$ Research$ into$ the$ signalling$
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lipids$and$ lipid+laden$macrophages$ (foam$cells),$occupy$ the$sub+endothelial$space,$
which$is$capped$by$fibrous$connective$tissue$[3].$Thereafter,$an$inflammatory$response$
occurs,$ which$ is$ characterized$ by$ the$ recruitment$ and$ accumulation$ of$ other$
leukocytes$ including$ lymphocytes$ and$ mast$ cells$ in$ the$ sub+endothelial$ space.$
Interaction$ between$ monocytes,$ macrophages,$ foam$ cells,$ and$ T+cells$ initiates$ a$
cellular$and$humoral$immune$response,$leading$to$a$chronic$inflammatory$state$and$








and$ unstable,$ are$ defined,$ depending$ on$ the$ balance$ between$ the$ formation$ and$



























Diagnosis$ of$ STEMI$ and$ NSTEMI$ involves$ the$ clinical$ assessment$ of$ a$ range$ of$
markers$including$electrocardiogram$(ECG),$elevated$levels$of$the$biomarkers$cardiac$
troponin$(cTn)$or$creatine$kinase$myocardial$band$(CK+MB),'echocardiogram,$and$a$
range$ of$ imaging$ techniques$ including$ magnetic$ resonance$ imaging$ (MRI)$ [11].$
Elevated$levels$of$blood$cTn$or$CK+MB$reflect$myocardial$injury$and$the$subsequent$
necrosis$ of$ myocardial$ cells$ [12+14].$ Although$ these$ markers$ do$ not$ explain$ the$















The$ predominant$ aims$ of$ MI$ treatment$ are$ to$ re+establish$ myocardial$ perfusion,$
minimize$the$myocardial$damage$sustained,$and$prevent$subsequent$complications.$
The$therapeutic$management$of$MI$is$tailored$to$the$patient’s$final$diagnosis.$Given$
the$differences$ in$ the$underlying$pathophysiology,$different$ treatment$strategies$are$
adopted$ for$ STEMI,$ NSTEMI,$ and$ UA.$ In$ STEMI$ patients,$ there$ is$ usually$ total$
occlusion$of$ the$ infarct+related$artery,$and$therefore$requires$ immediate$reperfusion$
therapy$ to$ retrieve$ normal$ coronary$ blood$ flow$ and$ minimize$ acute$ ischemic$
myocardial$ injury.$ Primary$ percutaneous$ coronary$ intervention$ (PPCI)$ and$
thrombolysis$are$two$commonly$used$reperfusion$strategies,$both$of$which$must$be$
administered$ promptly$ and$ effectively$ after$ the$ onset$ of$ acute$ MI$ to$ salvage$
myocardium,$limit$MI$size,$preserve$left$ventricular$systolic$function,$and$prevent$long$
term$development$of$heart$failure$and$therefore$reduce$mortality$[16].$The$importance$
of$PPCI$ in$salvaging$myocardial$ tissue$ is$ illustrated$ in$Figure$1.1.$Critically,$ longer$
intervals$ between$ the$ onset$ of$ STEMI$ patient$ symptoms$ such$ as$ chest$ pain,$ and$
complete$ restoration$of$ coronary$ reperfusion,$ known$as$ the$ ‘onset+to+balloon$ time’,$
have$been$shown$to$correlate$directly$with$mortality$and$morbidity$in$STEMI$patients$
[17].$While$thrombolysis$can$be$administered$quickly$and$performed$relatively$easily,$
PPCI$ is$ superior$ at$ reducing$mortality$ and$major$ cardiovascular$ events,$ achieving$
effective$ reperfusion$ in$ over$ 90+95%$ of$ cases,$ and$ is$ therefore$ the$ current$ gold+
standard$method$for$treating$acute$STEMI$providing$it$can$be$performed$expeditiously$
[18,$ 19].$ European$ guidelines$ recommend$ PPCI$ over$ thrombolytic$ therapy$ in$ all$






















arteries$ and$ improving$ collateral$ flow$ to$ ischemic$ areas.$ β+blockers$ inhibit$ β1+







salvaging$ viable$myocardium,$ limiting$MI$ size,$ preserving$LV$systolic$ function,$ and$
preventing$ heart$ failure.$ Reperfusion$ therapy$ has$ therefore$ significantly$ improved$
clinical$outcome$and$patient$survival$following$acute$MI$[24,$25].$However,$this$process$
of$ reperfusion$ itself$ can$ independently$ induce$ cardiomyocyte$ death,$ by$ a$ process$
known$as$ischaemia$reperfusion$(I/R)$injury$[26,$27].$This$is$believed$to$be$a$result$of$
free$ radicals,$ calcium$ build+up,$ acidosis,$ inflammation$ and$ accumulation$ of$
neutrophils,$all$of$which$accumulate$to$the$opening$of$the$mitochondrial$permeability$




Four$ major$ components$ of$ myocardial$ I/R$ injury$ are$ recognisedo$ reperfusion$




myocardial$ ischemia$ reperfusion$ injury.$ The$ first$ two$ of$ these$ are$ transient$ and$
reversible,$in$contrast$to$the$latter$two$which$are$irreversible$and$contribute$up$to$50%$
of$ the$ final$ infarct$ size$ (Figure$1.1)$ [24,$27,$28].$Historical$efforts$ to$ therapeutically$
target$myocardial$reperfusion$injury$have$proved$disappointing$to$date,$and$the$varying$
susceptibility$ of$ an$ individual$ to$ reperfusion$ injury$ alongside$ the$ narrow$window$of$
opportunity$in$which$to$intervene,$adds$to$the$complexity$of$this$process.$Despite$this,$
more$recent$studies$using$a$variety$of$novel$treatments$have$shown$promise$in$proof+








one$ heart$ attack$ occurring$ every$ three$minutes,$ and$ over$ half$ a$million$ individuals$
being$diagnosed$with$subsequent$heart$failure$[33].$Progression$to$heart$failure$after$
MI$is$multifactorial,$depending$on$the$extent$of$myocardial$damage$at$the$time$of$MI,$
recurrent$ myocardial$ ischemia,$ infarct$ size,$ ventricular$ remodelling,$ stunned$
myocardium,$MVO,$ and$mechanical$ complications$ [34,$ 35].$ Aside$ from$ the$ loss$ of$
myocardial$tissue$directly$damaged$during$the$initial$insult$of$acute$MI,$one$of$the$most$
critical$ complications$ of$ MI$ and$ prevailing$ cause$ of$ heart$ failure$ is$ adverse$ left$
ventricular$ remodelling$ [36].$ Immediately$ post+myocardial$ infarction,$ the$ heart$
undergoes$remodelling$to$attempt$to$maintain$cardiac$function$and$output.$In$around$
30%$of$ cases,$ dependent$ on$ infarct$ size,$ this$ remodelling$ process$ is$maladaptive,$
causing$a$further$decline$in$cardiac$function.$Such$patients$are$at$the$greatest$risk$of$
symptomatic$heart$failure$or$sudden$death$due$to$lethal$arrhythmia$[37].$Multiple$major$
mechanisms$ contribute$ to$ adverse$ left$ ventricular$ remodelling$ including$ early$ sub+
acute$ phase$ infarct$ expansion,$ subsequent$ infarct$ extension$ into$ adjacent$ non+











to$ inhibit$ progressive$ LV$ remodelling$ and$ improve$ clinical$ outcome$ in$MI$ [40,$ 41].$
Arrhythmic$ complications$ are$ another$ deleterious$ consequence$ of$ acute$ MI,$








Currently,$ the$ treatment$ of$ myocardial$ ischemia$ reperfusion$ injury$ is$ primarily$
supportive,$ as$ no$ specific$ target+oriented$ therapy$ has$ been$ validated$ so$ far.$
Therapeutic$ approaches$ to$ protect$ against$ myocardial$ ischemia+reperfusion$ injury$
however$remain$an$active$area$of$ investigation$given$ the$detrimental$effects$of$ this$






pre+conditioning$ [48,$ 49],$ ischemic$ post+conditioning,$ and$ remote$ ischemic$





demonstrate$ an$ attenuation$ of$ I/R$ injury$ as$ determined$ by$ improved$ LV$ function,$





inhibition$ of$ Na+/K++ATPase$ and$ by$ the$ hyperactivation$ of$ Na+/H+$ exchanger$ in$
cardiomyocytes$during$ischemia$and$reperfusion.$Atrial$natriuretic$peptide$(ANP)$and$
phosphodiesterase$ 5$ (PDE5)$ inhibitors$ have$ also$ shown$ beneficial$ effects$ in$
preventing$myocardial$ischemia$reperfusion$injuryo$clinical$studies$of$PDE5$inhibitors$
appear$ to$ act$ similar$ to$ cardiac$ pre+conditioning$ [57],$ while$ administration$ of$ ANP$
intravenously$at$the$time$of$reperfusion$reduces$infarct$size$and$improves$ventricular$
function$in$porcine$models$[58].$A$large$number$of$clinical$trials$have$also$investigated$
the$ effect$ of$ Glucose+insulin+potassium$ (GIK)$ therapy$ which$ demonstrate$ that$ this$
approach$may$be$more$effective$at$reducing$infarct$size$when$administered$to$STEMI$
patients$ in$ the$ ambulance$ prior$ to$ reperfusion$ [59].$ Through$ its$ function$ as$ an$
insulinotropic$incretin,$the$Glucagon+like$peptide+1$(GLP+1)$receptor$agonist$known$as$
Exenatide$offers$protection$during$I/R,$which$has$now$been$translated$into$the$clinical$
setting$ whereby$ Exenatide$ is$ administered$ during$ reperfusion$ [60].$ Intracoronary$
adenosine$ has$ been$ widely$ evaluated$ in$ clinical$ studies,$ demonstrating$







aimed$ to$ determine$ the$ effect$ of$ intravenous$ metoprolol$ on$ infarct$ size$ when$
administered$ immediately$ prior$ to$ reperfusion,$ showed$ cardioprotection$ of$ this$ β+
blocker$ via$an$ increase$ in$myocardial$ salvage$without$ complications$ [66].$Other$β+
blockers$such$as$nebivolol$have$also$shown$cardioprotective$potential$[67],$however$
sufficient$ pre+clinical$ investigation,$ including$ reproducible$ results$ in$multiple$ animal$
models,$ is$required$before$ large+scale$clinical$ testing.$Glycoprotein$IIb/IIIa$ inhibitors$
were$developed$for$ the$reduction$of$ thrombotic$events$due$to$ their$potent$effect$on$
platelets$and$platelet+leukocyte$aggregates$implicated$in$ischemia+reperfusion$injury.$
Clinical$ trials$ investigating$ abciximab$ showed$ that$ this$ potent$ glycoprotein$ IIb/IIIa$
inhibitor$ can$ reduce$ infarct$ size$ and$ lead$ to$ improved$ clinical$ outcomes$ when$
administered$early$to$MI$patients$[68]$or$via$an$intracoronary$route$[69].$Over$recent$














The$ red$ dashed$ line$ illustrates$ the$ development$ of$ infarct$ size$ over$ time$ without$
reperfusion$ therapy$ (PPCI).$ Myocardial$ Ischemia$ leads$ to$ irreversible$ damage$ of$
cardiac$tissue$which$continues$until$the$entire$area$at$risk$has$undergone$infarction.$
The$ yellow$ dashed$ line$ illustrates$ the$ extent$ of$ damage$ with$ PPCI$ treatment.$
Reperfusion$ leads$ to$ I/R$ injury,$ which$ has$ shown$ to$ compromise$ the$ benefit$ of$
reperfusion$ and$ contribute$ up$ to$ 50%$ of$ total$ infarct$ size.$ The$ green$ dashed$ line$
demonstrates$the$theoretical$infarct$size$following$PPCI$in$the$absence$of$subsequent$

























As$ the$ human$ heart$ has$ negligible$ endogenous$ regenerative$ capacity,$ repair$ and$
remodelling$of$the$infarcted$myocardium$requires$a$tightly$regulated$immune$response$
[72].$Repair$of$the$infarcted$myocardium$occurs$as$a$sequence$of$three$distinct$and$
overlapping$ phaseso$ the$ inflammatory$ phase,$ the$ proliferative$ phase,$ and$ the$
maturation$ phase.$Sudden$ coronary$ artery$ occlusion$ causes$ rapid$ ischemia$ of$ the$
myocardium$and$cardiomyocyte$death$within$the$ischemic$area.$Myocardial$necrosis$







both$ the$ balance$ and$ transition$ between$ the$ pro+inflammatory$ and$ the$ anti+
inflammatory$reparative$phases$can$exacerbate$acute$myocardial$IRI,$and$contribute$
to$post+MI$adverse$LV$remodeling.$Adverse$LV$remodelling$is$a$process$whereby$the$
LV$ undergoes$ geometric$ and$ functional$ changes$ following$ acute$ MI,$ including$
dilation/thinning$of$the$infarcted$tissue$and$hypertrophy$of$non+infarcted$myocardium,$











(TLR)s$ in$ a$ number$ of$ cell$ types$ including$ resident$ cardiac$ macrophages,$













C3$ fragments,$ within$ the$ myocardium$ of$ experimental$ models$ of$ MI$ [80].$ The$
complement$ cascade$ is$ acutely$ activated$ within$ hours$ of$ MI,$ as$ supported$ by$
augmented$expression$of$complement$genes$in$ischemia$and$reperfusion$[81].$During$
this$process,$C3$and$C5$cleavage$ fragments$contribute$ to$ initiation$of$ the$ immune$
response$in$IRI$by$chemoattraction$of$ immune$cells$and$membrane$attack$complex$




in$ the$early$ inflammatory$ response$after$necrotic$myocardial$ injury$ include$ reactive$
oxygen$species$(ROS)$[83],$cardiomyocyte+derived$High$Mobility$Group$Box$(HMGB1)$
[84],$Interleukin$1$alpha$(IL+1α)$[85]$and$extracellular$RNAs$[86].$Activation$of$these$
innate$ signalling$ pathways$ converges$ onto$ the$ activation$ of$ the$ key$ transcription$
factor,$nuclear$ factor$kappa+light+chain+enhancer$of$activated$B$cells$(NFκB),$which$
induces$ gene$ transcription$ of$ factors$ promoting$ inflammation$ including$ cytokines,$
chemokines,$ and$ adhesion$ molecules,$ by$ multiple$ cell$ types$ including$ endothelial$
cells,$fibroblasts,$cardiomyocytes,$resident$cardiac$mast$cells,$and$macrophages$[87].$
Upregulation$ of$ proinflammatory$ cytokines,$ namely$ tumor$ necrosis$ factor$ alpha$
(TNF#),$ Interleukin$1$Beta$ (IL+1β)$ and$ Interleukin$6$ (IL+6),$ and$ chemokines,$ is$ the$
hallmark$of$ the$ inflammatory$phase$of$ infarct$healing,$which$generates$chemotactic$
gradients$that$recruit$ leukocyte$subpopulations$to$the$infarcted$area$via$interactions$
with$corresponding$chemokine$ receptors.$ $ Increased$synthesis$of$TNF#,$ IL+1β$and$
members$of$the$IL+6$family,$induce$endothelial$cell$adhesion$molecule$synthesis$and$










infarcted$ myocardium.$ Following$ MI,$ the$ expression$ of$ chemokines$ including$
neutrophil$chemoattractant$IL+8$[88],$and$the$mononuclear$cell$chemoattractant$CCL2,$
are$ upregulated$ in$ the$ infarcted$ area$ [89].$Chemokines$ released$ in$ the$ infarct$ are$
immobilized$by$binding$to$glycosaminoglycans$on$the$endothelial$surface$and$in$the$
extracellular$ matrix,$ which$ generates$ localized$ high$ chemokine$ concentrations$ in$
areas$ of$ injury$ and$ provides$ directional$ signals$ for$ extravasation$ of$ leukocyte$
subpopulations$ into$ the$ infarcted$myocardium$ [90].$ This$ inflammatory$ response$ to$





While$ the$ intense$myocardial$ inflammatory$ response$ is$essential$ for$cardiac$ repair,$
unrestrained$activity,$temporal$prolongation,$or$spatial$expansion$of$the$inflammatory$
response$is$implicated$in$the$pathogenesis$of$adverse$remodelling$and$heart$failure$in$
patients$ with$ acute$MI$ [91+93].$ Excessive$ early$ inflammation$may$ augment$matrix$
degradation$causing$cardiac$rupture,$while$prolongation$of$the$inflammatory$reaction$
may$ impair$ collagen$deposition$ leading$ to$ formation$of$a$ scar$with$ reduced$ tensile$
strength,$thus$increasing$chamber$dilation.$An$excessive,$persistent$or$expanded$pro+
inflammatory$ response$ to$ cardiac$ I/R$ may$ worsen$ adverse$ LV$ remodelling$ by$
activating$ proteases$ [94]o$ increasing$ cytokine$ expression$ which$ may$ induce$
cardiomyocyte$ apoptosis$ and$ suppress$ contractilityo$ increasing$ matrix$ deposition$
which$may$result$ in$a$stiffer$ventricle$and$causes$diastolic$dysfunction$[95],$and$the$
activation$of$cardiac$fibroblasts$in$the$infarct$border$zone$which$may$expand$fibrosis$
into$ viable$ tissue.$Defective$ containment$ of$ the$ inflammatory$ reaction$may$ lead$ to$
extension$of$the$inflammatory$infiltrate$into$the$non+infarcted$myocardium,$enhancing$











tissue$ destruction,$ infarct$ size,$ cardiac$ dysfunction,$ and$ adverse$ ventricular$





Optimum$ repair$ of$ infarcted$ myocardial$ tissue$ and$ the$ prevention$ of$ adverse$ LV$
remodelling$ following$MI$ is$ therefore$critically$dependent$on$ the$ timely$suppression$
and$containment$of$inflammation.$Suppression$of$the$inflammatory$response$occurs$
as$ necrotic$ cells$ and$ cell$ fragments$ are$ cleared$ from$ the$ infarct,$ around$ day$ 3+4$
following$ MI.$ Although$ many$ cell$ types$ contribute$ to$ the$ resolution$ of$ myocardial$
inflammation,$ reparative$ M2$ macrophage,$ and$ Treg$ populations$ in$ particular$
contribute$to$ inflammatory$suppression$following$MI.$Neutrophils$undergo$apoptosis$
and$ are$ phagocytosed$ by$ macrophages,$ and$ there$ is$ a$ shift$ from$ inflammatory$













a$ myofibroblast$ phenotype.$ A$ combination$ of$ growth$ factors,$ cytokines,$ TGF+
β1/Smad3$signalling,$angiotensin$II,$and$altered$composition$of$the$extracellular$matrix$
(ECM)$ are$ particularly$ important$ reparative$ and$ fibrogenic$ mediators,$ inducing$
transdifferentiation$ of$ fibroblasts$ to$ secretory$myofibroblasts.$ Infarct$myofibroblasts$
express$ and$ secrete$ contractile$ proteins$ including$ alpha+smooth$ muscle$ actin$ (α+
SMA),$and$synthesize$and$deposit$ECM$proteins,$beginning$from$the$ infarct$border$
zone$and$progressing$toward$the$core$infarct$area$as$the$cells$migrate$along$the$newly$
synthesized$ ECM$matrix$ [99,$ 108+110].$ Myofibroblasts$ produce$ and$ deposit$ large$
amounts$of$interstitial$collagens$(initially$type$III$and$later$on,$during$the$infarct$healing,$




adequate$oxygen$and$nutrients$ to$myofibroblasts$ in$ the$metabolically$ active$ infarct$
[112].$ As$ the$ infarct$ is$ filled$ with$ matrix,$ cellular$ proliferation$ is$ suppressed$ and$
transition$ to$ the$maturation$phase$ follows.$Although$ the$ initial$ reparative$ fibrosis$ is$
crucial$for$preventing$rupture$of$the$ventricular$wall,$an$exaggerated$fibrotic$response$
or$ fibrosis$ outside$ the$ injured$ area$ is$ detrimentalo$ enhanced$ fibrosis$ during$ the$
proliferative$ phase$ contributes$ to$ stiffening$ of$ the$ left$ ventricle,$ reduced$ LV$
compliance,$ and$ adverse$ left$ ventricular$ remodelling,$ particularly$ if$ myofibroblasts$
remain$in$non+injured$areas$of$the$heart.$Conversely,$interference$with$the$reparative$












The$ final$ stage$ of$ infarct$ healing$ is$ the$maturation$ phase,$ whereby$matrix$ cross+
linking$leads$to$the$formation$of$a$dense$collagenous$scar,$marking$the$end$stage$of$
myocardial$ infarct$ repair.$ This$ occurs$ from$ weeks$ to$ months$ following$ MI$ [75].$$
Fibroblasts$become$quiescent$and$undergo$apoptosis,$resulting$in$the$suppression$
of$ collagen+based$ matrix$ synthesis$ and$ deposition$ which$ is$ critical$ to$ prevent$
exaggerated$fibrosis$and$adverse$remodelling.$$Temporary$infarct$vascular$networks$






as$ myofibroblasts$ disappear,$ resulting$ in$ an$ unstable$ scar$ prone$ to$ rupture.$








































































Activation$ of$ innate$ signalling$ pathways$ converges$ onto$ the$ activation$ of$ the$ key$
transcription$ factor$ NFκB$ which$ induces$ gene$ transcription$ of$ factors$ promoting$
inflammation$including$cytokines,$chemokines,$and$adhesion$molecules,$by$multiple$
cell$ types$ including$ endothelial$ cells,$ fibroblasts,$ cardiomyocytes,$ resident$ cardiac$




ultimately$ lead$ to$ extravasation$ of$ inflammatory$ cells$ into$ the$ infarct.$ $ Neutrophils,$
classical$monocytes$and$M1$Macrophages$dominate$the$inflammatory$phase$of$repair.$
These$cells$give$rise$to$non+classical$monocytes$and$M2$macrophages$which$promote$
the$second$anti+inflammatory,$proliferative$phase$of$ repair$ (around$day$4$ to$weeks$
post+MI).$ Myofibroblasts$ mediate$ collagen$ production$ and$ deposition$ to$ promote$
fibrosis$ and$ prevent$ cardiac$ rupture.$ The$ third$ stage$ of$ infarct$ healing$ is$ the$
























Monocytes$develop$ in$ the$bone$marrow$ from$HPSCs$ following$a$ transition$ through$












classical$ subsets$ [124].$Previous$studies$grouped$ intermediate$monocytes$with$ the$





population$ [125].$ In$ addition$ to$ having$ their$ own$ distinct$ immune$ cell$ marker$
expression$profile,$monocyte$subpopulations$also$perform$unique$functions.$Accurate$





It$ currently$ remains$ unclear$ whether$ non+classical$ monocytes$ arise$ from$ an$
independent$ bone$ marrow$ monocyte$ progenitor$ distinct$ from$ that$ of$ classical$
monocytes,$or$whether$classical$Ly6ChiCCR2hi$monocytes$serve$as$an$intermediate$
lineage$for$the$subsequent$generation$of$non+classical$Ly6CloCX3CR1hi$monocytes.$A$
number$ of$ murine$ studies$ support$ the$ notion$ that$ myeloid$ precursors$ in$ the$ bone$
marrow$ initially$give$ rise$ to$classical$Ly6ChiCCR2hi$monocytes,$which$subsequently$
transition$into$non+classical$Ly6CloCX3CR1hi$monocytes$over$time$[126+131].$In$this$
manner,$mouse$blood$monocyte$subpopulations$represent$stages$of$a$developmental$
sequence.$ In$ vitro$ studies$ suggest$ that$ this$ transition$ is$ performed$ over$ 24+48h,$
whereby$Ly6Chi$monocytes$gradually$down+regulate$Ly6C$expression$while$still$in$the$







exclude$ the$ existence$ of$ an$ alternative$ route$ for$ non+classical$ Ly6Clo$development$
independent$ of$ the$ classical$ Ly6Chi$ monocyte$ population.$ For$ example,$ selective$
impairment$ of$ Ly6Chi$ monocytes$ in' Irf8−/−$ mutant$mice$ or$Klf4+/+$ cells$ suggests$ an$
independent$ developmental$ pathway$ for$ non+classical$ Ly6Clo$monocytes,$ whereby$
dramatically$reduced$numbers$of$classical$Ly6Chi$monocytes$in$the$bone$marrow$does$













and$ bone$marrow,$ and$ Ly6Clo$patrolling$monocytes$ remaining$ in$ the$ bone$marrow$
undergo$apoptosis$due$to$arrest$in$the$S+phase$of$$cell$cycle$progression$[138].$Human$
non+classical$ CD14+CD16++$ monocytes$ (equivalent$ to$ mouse$ Ly6Clo$ patrolling$





During$ resting$state,$classical$monocytes$are$abundant$ in$ the$blood$and$ in$several$
non+inflamed$organs$ including$ the$spleen,$ lung,$ liver,$and$brain.$Following$ injury$or$






made$ up$ of$ ~60%$ classical$ monocytes$ and$ ~40%$ non+classical$ monocytes$ [144].$












in$ the$ circulation$ during$ basal$ conditions.$ The$ egress$ of$ bone$ marrow$
Ly6Chi$monocytes$ during$ steady$ state$ requires$ the$ engagement$ of$ the$ chemokine$
receptor$ CCR2$ [146].$ By$ contrast,$ most$ Ly6Clo$ monocytes$ gain$ access$ to$ the$
bloodstream$independently$of$CCR2$and$rely$on$the$transcription$factor$NR4A1$for$the$
differentiation$of$ circulating$Ly6Chi$monocytes$ into$Ly6Clo$monocytes$as$previously$
described$ [138].$ In$ this$ sense,$Ly6Clo$non+classical$monocytes$are$not$necessarily$
derived$from$the$bone$marrow$directly,$but$instead$originate$from$bone$marrow$Ly6Chi$






classical$ monocytes$ provides$ a$ timely$ mechanism$ of$ surveillance$ for$ the$ immune$
system$to$respond$to$inflammatory$stimuli$following$injury$or$infection.$The$patrolling$





monocytes,$ possibly$ due$ to$ reduced$ monocyte$ survival$ resulting$ from$ CX3CR1+
dependent$expression$of$anti+apoptotic$protein$B+cell$lymphoma$2$(BCL+2)$[151].$This$
CX3CL1/CX3CR1$ interaction$ promotes$ further$ adhesion$ of$ patrolling$ non+classical$
monocytes$to$the$vascular$endothelium$via$the$lymphocyte$function$antigen+1$(LFA+1)$
which$ is$ an$ integrin$ comprising$ CD11a$ and$ CD18$ that$ interact$ with$ Intercellular$
Adhesion$Molecule$1$(ICAM1)$and$Intracellular$Adhesion$Molecule$2$(ICAM2)$on$the$
endothelial$ cell$ surface$ [150].$ ICAM1$ and$ ICAM2$ behave$ in$ a$mutually$ redundant$
fashion$ to$ facilitate$ LFA+1$ dependent$ monocyte$ adhesion,$ and$ ICAM1/2$ double$
knockout$ mice$ demonstrate$ a$ dramatically$ reduced$ frequency$ of$ non+classical$
monocyte$adhesion$ to$ the$vasculature$ [125].$ In$ vivo$ inhibition$of$LFA+1$using$anti+
CD11a/CD18$ antibodies$ also$ leads$ to$ the$ prolonged$ dissociation$ of$ non+classical$
monocytes$from$the$endothelium$and$abolishes$patrolling$behaviour$[152].$Expression$





human$CD14+CD16++$non+classical$monocytes$are$ the$human$counterpart$ to$ these$
patrolling$Ly6Clo$monocytes$ in$mouse$ [124,$139,$153],$which$also$exhibit$patrolling$
























reduction$ in$classical$Ly6Chi$monocyte$emigration$ from$the$bone$marrow,$while$ the$
distribution$ of$ non+classical$ Ly6Clo$ monocytes$ is$ relatively$ normal$ [157].$ Classical$
Ly6Chi$ monocytes$ dominate$ the$ first$ phase$ (day$ 1+4)$ of$ the$ monocyte$ response$
following$MI$in$mouse,$and$differentiate$into$M1$pro+inflammatory$macrophages$that$







primarily$ exhibit$ patrolling$ behaviour$ along$ the$ vasculature$ by$ responding$ to$
endothelial$expressed$CX3CL1.$In$the$inflammation$that$ensues$following$MI,$vascular$
endothelial$ cells$ upregulate$ the$ expression$ of$ CX3CL1,$ allowing$ patrolling$ non+
classical$monocytes$to$firmly$arrest$and$adhere$to$the$vascular$lumen.$This$interaction$
permits$ the$ subsequent$ extravasation$ of$ non+classical$ monocytes$ into$ the$ injured$
myocardial$ tissue.$ In$ the$ later$stages$of$ repair,$pro+inflammatory$Ly6Chi$monocytes$
and$M1$macrophages$can$also$differentiate$into$pro+fibrotic$Ly6Clo$monocytes$and$M2$
macrophages$via$TGF+"$activation$and$have$attenuated$inflammatory$properties$[158],$
highlighting$ the$ plasticity$ of$ the$monocyte/macrophage$ lineage.$M2+like$ pro+fibrotic$
macrophages$promote$ the$reparative$phase$of$healing$by$stimulating$myofibroblast$
accumulation,$ angiogenesis,$ and$ collagen$deposition$ [158].$ This$ temporal$ biphasic$
monocyte$response$in$mouse$models$of$MI$has$also$been$reported$to$occur$in$human$
MI,$whereby$an$initial$rise$of$inflammatory$classical$CD14++CD16+$monocytes$at$day$














Importantly,$ disruption$ of$ the$ finely$ tuned$ balance$ between$ the$ early$ classical$
monocyte$and$subsequent$non+classical$monocyte$response$is$highly$detrimental$to$
infarct$ healing$ [113]o$ an$ excessive$ or$ prolonged$ inflammatory$ classical$ monocyte$








of$ the$ Ly6Clo$ non+classical$ monocyte$ response.$ Furthermore,$ in$ the$ absence$ of$








years$ by$ new$ insights$ into$ monocyte$ behaviour,$ particularly$ of$ the$ non+classical$
monocyte$subpopulation.$This$evidence$has$suggested$a$much$earlier$ role$of$non+
classical$monocytes$ than$that$originally$ thoughto$ real+time$ imaging$revealed$a$rapid$
infiltration$of$CX3CR1+$monocytes$ into$ the$ injured$site$within$several$minutes$after$




by$ intravital$ 2+photon$ imaging$ of$ the$ beating$ heart$ that$ CX3CR1hi$ monocytes$ are$
rapidly$ recruited$ to$ the$ heart$within$ one$hour$ of$ reperfusion,$ and$ displayed$ rolling,$






inflammatory$ profile$ than$ previously$ believed.$ Non+classical$ monocytes$ have$
traditionally$ been$ viewed$ as$ the$ anti+inflammatory,$ pro+fibrotic$ subpopulation$ of$





1β$ among$ monocyte$ subsets$ [154,$ 164+167],$ via$ stimulation$ of$ TLR$ 2,$ 5$ and$ 9.$
Notably,$administration$of$a$TLR2$antagonist$just$five$minutes$before$reperfusion$has$












relative$ to$ their$ classical$ counterpart,$ including$ LFA+1,$ MAC+1,$ CX3CR1$ and$ TNF$
























the$ case$ of$ CD16+$ monocytes$ however$ this$ study$ did$ not$ differentiate$ CD16+$
intermediate$from$CD16++$non+classical$monocytes$and$therefore$the$exact$dynamics$
of$each$monocyte$subpopulation$was$not$determined.$In$a$similar$study,$peak$levels$
of$ classical$ (CD14++CD16+)$ monocytes$ at$ day$ 2.8$ post+MI,$ but$ not$ those$ of$ non+
classical$ monocytes,$ were$ significantly$ higher$ in$ patients$ with$ MVO$ than$ in$ those$
without$MVO$[171].$STEMI$patient$high$counts$of$classical$monocytes$at$~day$5$have$
been$ shown$ to$ predict$ impaired$ LVEF,$ larger$ infarct$ size,$ and$ MVO,$ while$ high$
classical$ monocyte$ counts$ at$ 4+month$ follow$ up$ were$ negatively$ associated$ with$
regional$systolic$LV$function$[172].$
$
There$ is$ also$ evidence$ that$ the$ intermediate$ monocyte$ population$ independently$
predicts$ cardiac$ outcome$ in$ STEMI$ patients.$ In$ a$ study$ of$ 100$ STEMI$ patients,$
monocytosis$of$intermediate$(CD14++CD16+)$monocytes$during$the$acute$phase$after$
STEMI$ $ (day$ 1+7)$ was$ predictive$ of$ 2+year$ post$MI$major$ adverse$ cardiac$ events$
following$PPCIo$ [79].$Furthermore,$analysis$of$post+reperfusion$monocyte$counts$at$
day$1,3$and$7$following$PCI$showed$that$STEMI$patients$had$a$60+80%$increase$in$
total$ monocyte$ counts$ and$ a$ disproportionate$ increase$ (3+fold)$ in$ intermediate$






within$ three$ years$ of$ study$ enrollment$ [174].$ The$ non+classical$ (CD14+CD16++)$







also$ been$ reported$ in$ the$ context$ of$ stroke$ patients$ [176+178].$ A$ trend$ between$
circulating$non+classical$monocytes$at$day$5$post+MI$and$worse$systolic$LV$function$at$
follow$up$has$also$been$ reported$ [245].$Monocytosis$of$ the$ intermediate$monocyte$
population$ at$ day$ 1+7$ post+MI$ is$ reported$ to$ predict$ 2$ year$major$ adverse$ cardiac$








Monocyte$ subpopulations$ therefore$ appear$ to$ specifically$ respond$ to$ the$ extent$ of$
cardiac$ injury,$ suggesting$ that$manipulation$ of$monocyte$ heterogeneity$ could$ be$ a$
novel$ therapeutic$ target$ for$ salvaging$ ischemic$ damage,$ or$ may$ offer$ reliable$
biomarkers$to$prioritise$patients$for$follow$up$treatments/management.$Further$studies$
are$ however$ required$ to$ determine$ the$ precise$ dynamics$ of$ circulating$ monocyte$
subpopulations$ in$ STEMI$ patients$ following$ reperfusion.$ In$ particular,$ the$
aforementioned$ studies$ have$ investigated$ circulating$ monocyte$ subpopulation$



















a$highly$ complex$process,$ requiring$adhesion$ to$ the$ vascular$ luminal$ endothelium,$
transendothelial$migration,$ and$ subsequent$ leukocyte$ chemotaxis,$ all$ of$which$ are$
tightly$ regulated$ by$ members$ of$ the$ chemotactic$ cytokine$ family$ known$ as$
chemokines.$ Chemokines$ are$ a$ group$ of$ small$ (8–14$ kDa),$ structurally+related$
secreted$ proteins$ which$ regulate$ leukocyte$ trafficking$ via$ their$ interactions$ with$
chemokine$ receptors,$ a$ large$ family$ of$ seven+transmembrane$ domain,$ G+protein$
coupled$ receptors.$ They$ target$ all$ types$ of$ leukocytes$ including$ haematopoietic$
precursors,$mature$leukocytes$of$the$innate$immune$system$as$well$as$naive,$memory,$
and$ effector$ lymphocytes$ [179].$ Human$ chemokines$ are$ classified$ into$ four$
subfamilies,$based$on$the$position$of$the$first$two$of$four$highly$conserved$N+terminal$
cysteine$ residues:$ CXC,$ CC,$ and$ CX3C$ [6].$ The$ C$ chemokine$ sub+family$ is$ an$
exception$ which$ has$ only$ one$ N+terminal$ cysteine$ residue.$ Uniquely,$ the$ CX3C$
chemokine$family$is$comprised$of$only$a$single$chemokine,$CX3CL1,$also$known$as$
Fractalkine$ (FKN).$ In$addition$ to$ their$structural$classification,$chemokines$are$also$
defined$ into$ two$ functional$ subsetso$ inflammatory$ and$ homeostatic$ chemokines.$
Inflammatory$chemokines$are$upregulated$in$response$to$inflammation,$infection,$and$
tissue$injury.$They$often$have$broad$target$cell$selectivity$and$act$on$both$innate$and$
adaptive$ cells$ of$ the$ immune$ system.$ In$ contrast,$ homoeostatic$ chemokines$ are$
constitutively$expressed$in$specific$tissues$where$they$regulate$leukocyte$homing.$This$
includes$haematopoiesis$ in$ the$bone$marrow$and$ thymus,$ the$ initiation$of$adaptive$
immune$ responses$ in$ the$ spleen$ and$ lymph$ nodes,$ and$ immune$ surveillance$ of$
healthy$ peripheral$ tissues.$ Several$ chemokines$ are$ reported$ to$ be$ ‘dual$ function’$
chemokines,$whose$properties$cannot$be$assigned$to$either$of$the$two$groups$[179].$
$
Binding$ of$ endothelium+associated$ chemokines$ to$ leukocyte+expressed$ chemokine$
receptors$is$required$for$the$extravasation$of$leukocytes,$by$inducing$a$rapid$increase$






the$underlying$basement$membrane$ into$ the$ tissue$whereby$a$chemokine$gradient$
directs$ their$ migration$ [182].$ Leukocyte$ adhesion$ and$ transmigration$ is$ largely$
determined$ by$ the$ selectively$ of$ the$ chemokine$ system,$ whereby$ only$ those$
leukocytes$that$are$responsive$to$the$chemokines$present$on$the$local$endothelium$at$
the$ given$ vascular$ site$ are$ able$ to$ transmigrate.$ Such$ selectivity$ ensures$ specific$
appropriate$ tissue$ distribution$ of$ distinct$ leukocyte$ subsets$ under$ both$ normal$ and$
inflammatory$ conditions$ [183].$ Another$ essential$ component$ of$ transendothelial$
migration$ is$ the$ immobilisation$ of$ chemokines$ on$ endothelial$ surfaces$ through$
interactions$with$glycosaminoglycans$(GAGs)$[184].$Importantly,$a$breakdown$in$the$
control$ of$ leukocyte$ mobilisation$ contributes$ to$ chronic$ inflammatory$ diseases,$
suggesting$that$therapeutic$interference$of$chemokine$function$may$offer$a$promising$






known$ chemokines,$CX3CL1$ exists$ in$ two$ isoformso$ transmembrane$CX3CL1$ and$
soluble$ CX3CL1,$ which$ results$ from$ proteolytic$ cleavage$ of$ membrane+anchored$
CX3CL1$ by$ the$ enzymes$ A$ Disintegrin$ and$ metalloproteinase$ domain+containing$
protein$10$(ADAM10)$or$ADAM17$[185].$These$isoform$properties$are$also$true$for$the$
chemokine$ CXCL16$ [186].$ Such$ isoforms$ allow$ for$ both$ the$ chemoattractive$ and$
















mediated$ by$ selectins$ (Figure$ 1.5A).$ Leukocyte+expressed$ L+selectin$ is$ the$ most$
important$adhesion$molecule$to$initiate$leukocyte$tethering$and$rolling$on$the$vascular$
endothelium$via$interaction$with$endothelial+expressed$Glycosylation+dependent$Cell+
adhesion$Molecule+1$ (GlyCam+1)$ [189].$ Following$ this$ binding,$ P+selectin$ interacts$
with$ the$ selectin$ ligand$ P+selectin$ glycoprotein$ ligand+1$ (PSGL+1)$ expressed$ by$
leukocytes.$Binding$of$selectins$to$their$respective$ ligands$ is$a$rapid$process$which$
allows$fast$flowing$leukocytes$to$initially$be$captured$from$the$bloodstream$and$bind$
tentatively$ to$ the$ endothelium$ as$ they$move$ along$ in$ a$ process$ known$ as$ rolling.$
Binding$ of$ E+selectin$ to$ its$ ligand$ E+Selectin$ Glycoprotein$ Ligand+1$ (ESGL+1)$
expressed$by$leukocytes$promotes$‘slow$rolling’$due$to$partial$activation$of$leukocyte$
integrins.$This$rolling$and$slow$rolling$behaviour$brings$leukocytes$into$contact$with$the$
endothelium$ to$ induce$ further$ activation$ of$ leukocytes$ by$ chemokines$ and$
proinflammatory$ agents$ expressed$ by$ endothelial$ cells.$ This$ leads$ to$ activation$ of$
leukocyte+expressed$integrins$including$the$"1+integrin$Very$Late$Antigen$4$(VLA+4)$
which$ binds$ to$ endothelial+expressed$ Vascular$ Cell$ Adhesion$ Protein$ 1$ (VCAM+1)$$
This$integrin+ligand$interaction$allows$leukocytes$to$arrest$on$the$vascular$endothelial$
surface.$ The$ "2+integrin$ LFA+1$ (CD11a/CD18)$ expressed$ by$ leukocytes$ is$ also$
involved$ in$ the$ firm$ adhesion$ of$ leukocytes$ through$ interaction$ with$ endothelial+
expressed$ ICAM+1.$ This$ firm$ adhesion$ then$ allows$ leukocytes$ to$ crawl$ along$ the$
vasculature,$ before$ extravasating$ at$ endothelial$ cell+cell$ junctions$ in$ a$
platelet/endothelial$ cell$ adhesion$ molecule$ 1$ (PECAM)+dependent$ mechanism$
towards$the$site$of$inflammation$or$injury$[190,$191].$PECAM$is$expressed$diffusely$on$
the$surfaces$of$most$leukocytes$and$is$concentrated$at$the$borders$of$endothelial$cells$









selectin/Integrin$ interaction$ [192,$ 193]$ (Figure$ 1.5B).$ In$ this$ scenario,$ circulating$
CX3CR1+$leukocytes$are$captured$and$bound$by$endothelium+expressed$CX3CL1$in$
an$interaction$that$has$a$higher$affinity$than$VCAM+1$binding$to$integrins$[194].$This$
CX3CL1/CX3CR1+mediated$ interaction$ between$ leukocytes$ and$ vascular$
endothelium$ initially$ occurs$ independently$ of$ other$ adhesion$ molecules$ [195]$ and$
facilitates$ the$patrolling$behaviour$ of$CX3CR1+$monocytes$ in$ the$blood$ [144].$This$
CX3CL1/CX3CR1$ interaction$ then$ promotes$ further$ adhesion$ of$ patrolling$ non+
classical$ monocytes$ to$ vascular$ endothelium$ via$ interaction$ between$ LFA+1$ and$
ICAM1/2$ on$ the$ endothelial$ cell$ surface$ [150].$ ICAM1$ and$ ICAM2$ behave$ in$ a$
redundant$ fashion$ to$ facilitate$LFA+1$dependent$monocyte$adhesion,$and$ ICAM1/2$
knockout$ mice$ demonstrate$ a$ dramatically$ reduced$ frequency$ of$ non+classical$
monocyte$adhesion$ to$ the$vasculature$ [125].$ In$ vivo$ inhibition$of$LFA+1$using$anti+
CD11a/CD18$ antibodies$ leads$ to$ the$ prolonged$ dissociation$ of$ non+classical$
monocytes$from$the$endothelium$and$abolishes$patrolling$behaviour$[152].$Expression$
of$ CX3CR1$ and$ LFA+1$ by$ non+classical$ monocytes$ is$ therefore$ crucial$ to$ their$
patrolling$behaviour.$Under$flow$conditions,$a$high$frequency$of$CD16+$intermediate$
and$non+classical$monocytes$ have$been$ shown$ to$ arrest$ on$membrane+expressed$
CX3CL1$[196].$This$patrolling$behaviour$occurs$continuously$during$basal$conditions$
as$ CX3CR1+$ cells$ act$ on$ ‘stand+by’$ for$ inflammatory$ stimuli.$ This$ method$ of$





The$ soluble$ form$ of$ CX3CL1$ is$ released$ following$ constitutive$ shedding$ of$
transmembrane$endothelial$CX3CL1$which$is$mediated$by$ADAM10,$while$shedding$
under$inflammatory$conditions$is$mediated$primarily$by$ADAM17$[197,$198].$CX3CL1$
functions$ as$ a$ conventional$ chemokine,$ demonstrating$ efficient$ recruitment$ of$
CX3CR1+expressing$ monocytes,$ NK$ cells,$ T$ cells,$ and$ dendritic$ cells$ to$ specific$
tissues.$ Importantly,$ this$ chemotactic$ function$ of$ the$ CX3CL1/CX3CR1$ axis$ in$
regulating$ leukocyte$ recruitment$ has$ been$ associated$ with$ the$ pathophysiology$ of$


















































In$ response$ to$ myocardial$ damage$ following$ cardiac$ I/R,$ necrotic$ cardiomyocytes$
release$ alarmins$ which$ activate$ innate$ immune$ cells$ and$ thereby$ increase$ the$
production$ of$ pro+inflammatory$ cytokines$ IFN+γ,$ IL+1,$ TNF+α,$ IL+10,$ and$ IL+6.$
Stimulation$ of$ vascular$ endothelial$ cells$ by$ these$ pro+inflammatory$ cytokines$
upregulates$the$expression$of$CX3CL1$by$the$endothelium.$This$increased$expression$






During$ this$ process,$ CX3CL1+CX3CR1$ interaction$ promotes$ further$ monocyte$
adhesion$via$interactions$between$lymphocyte$function+associated$antigen$1$(LFA+1)$




the$ cleavage$ of$ endothelial+expressed$ membrane+anchored$ CX3CL1$ into$ soluble$



































































non:classical!monocytes,!can! interact!with! the!endothelium!using!a!method! that! is! independent!of!P:selectin/Integrin! interaction.!
Circulating!CX3CR1+!leukocytes!are!captured!and!bound!by!endothelium:expressed!CX3CL1!in!an!interaction!that!initially!occurs!
independently! of! other! adhesion! molecules! and! facilitates! the! patrolling! behaviour! of! CX3CR1+! monocytes! in! the! blood.! This!
interaction!promotes!further!adhesion!of!patrolling!non:classical!monocytes!to!vascular!endothelium!via!interaction!between!LFA:1!









The! chemotactic! function! of! the! CX3CL1/CX3CR1! axis! in! regulating! leukocyte!
recruitment!has!been!associated!with!the!pathophysiology!of!an!extensive!range!of!
diseases,! including! numerous! inflammatory! disorders,! infections,! neurological,! and!
tumorigenesis!processes! [185,!202].!Among! these!diseases,! the!CX3CL1/CX3CR1!
axis!has!been!frequently!implicated!in!determining!the!extent!of!myocardial!damage!
following!cardiac!I/R.!Accumulative!evidence!from!in!vitro!studies,!mouse!models!of!
cardiac! I/R,! and! STEMI! patients! suggests! that! the! CX3CL1/CX3CR1! system! is!
detrimental!to!myocardial!repair!following!cardiac!I/R.!In!vitro!evidence!has!shown!that!
exposure! of! cultured! rat! cardiomyocytes! to! CX3CL1! increases! cardiomyocyte!
expression! of! natriuretic! peptide! A! (NTRproBNP),! a! marker! of! left! ventricular!
dysfunction![203].!Mouse!models!of!permanent!MI!have!demonstrated!that!CX3CL1!
gene! and! protein! expression! are! enhanced! in! the! failing! heart! [204],! and! that!
neutralization! of! CX3CL1! using! antiRCX3CL1! antibody! reduces! macrophage!
recruitment! to! the! injured! myocardium,! diminishes! infarct! size,! and! improves! MIR
induced! heart! failure.!Other! reports! have! demonstrated! that! antiRCX3CL1! (TP233)!
reduces!cardiac!remodelling!after!transRaortic!constriction!and!MI,! improves!cardiac!
function,!and!decreases!infarct!size!(2R3!weeks)!after!permanent!MI![203].!In!a!porcine!
model! of! cardiac! I/R! injury,! PCI! stents! coated! with! a! CX3CR1! antagonist!
(AZ12201182),! led! to! a! decrease! in! monocyte! recruitment! and! reduced! stenosis!
without! affecting! reRendothelialisation! [205].! ! Based! on! these! studies! it! therefore!
appears!that!the!action!of!CX3CL1/CX3CR1!in!response!to!cardiac!I/R!is!detrimental!
to!infarct!healing.!Since!inhibition!of!the!CX3CL1/CX3CR1!axis!has!proven!successful!


















increased! circulating! CX3CR1+! lymphocytes,! possibly! due! to! an! increase! in!
recruitment!of!cytotoxic!T!cells!to!the!injured!heart!tissue![209].!This!study!established!





In! addition! to! its! apparent! role! in! compromising! cardiac! repair! and! promoting!
myocardial! damage,! the! CX3CL1/CX3CR1! axis! has! also! been! shown! to! hold!
predictive!value!for!those!at!risk!of!cardiovascular!disease.!It!has!been!reported!that!
the! CX3CR1! I249! allele! markedly! reduces! the! risk! of! acute! coronary! events!
independent! of! established! coronary! risk! factors,! and! is! therefore! an! independent!
genetic! risk! factor! for!CAD! [211].!A!direct!correlation!between!CX3CR1!V249I!and!
T280M!polymorphisms!with!the!occurrence!of!acute!fatal!MI!has!also!been!reported!
[212].! These! alleles! were! found! to! code! for! CX3CR1! that! is! overexpressed! by!
activated! inflammatory!cells,!with!a!higher!binding!affinity! for!CX3CL1.! ! It!has!also!
been! shown! that! homozygosity! for! the! rare! CX3CR1! alleles! I249! and! M280! is!
associated!with!an!increased!risk!of!brain!infarction![213].!This!study!also!showed!that!






antagonist!of!CX3CR1!reduced!the! levels!of! inflammatory!monocytes!which! in! turn!






[216].! Injection! of! a! longRacting! CX3CL1! into! mice! was! also! found! to! attenuate!




























treatment!with! the! ligand! reduced! serumRinduced! and! oxysterolRinduced!monocyte!






CX3CL1! increased! levels!of!hypoxiaRinducible! factorR1α! (Hif1α),!which! is! known! to!
regulate!the!expression!of!genes!regulating!both!apoptosis!and!angiogenesis![219].!
Interestingly,! recombinant! soluble! CX3CL1! (full! length! without! transmembrane!
anchor,! aa! 1R337)! has! been! shown! to! protect! primary! human! monocytes! from!









of! CX3CL1! did! not! recover! the! depleted! population! of! circulating! nonRclassical!
monocytes! [226].!The!CX3CL1/CX3CR1!axis!also! functions! to! reduce!apoptosis! in!
pancreatic! tumour! cells! [227]c! CX3CL1! induced! activation! of! the! Akt/NF!B/p65!
signalling! cascade! to! increase! the! expression! of! BclRXL! and! BclR2,! and! inhibited!
caspase!3!cleavage,! thereby! inhibiting!apoptosis! in!pancreatic! cells!and!promoting!
tumour! development.! ! This! effect!was! blocked! by! inhibition! of! the!NF!B!pathway.!





demonstrated! the! importance! of! CX3CL1/CX3CR1! signalling! in! the! adhesion! and!
migration!of!CX3CR1+!cells,!predominantly!monocytes.!CX3CL1Rinduced!activation!of!









gene! family! member! A! (RhoA)! downregulates! CX3CR1! and! reduces!
monocyte/macrophage! recruitment! to! inhibit! chronic! rejection! of! mouse! cardiac!
allografts,! suggesting! a! role! for! the! RhoA/ROCK! pathway! in! CX3CR1Rmediated!
monocyte!function.!In!mouse!models,!monocytes!have!been!shown!to!rely!on!MAPKR




induces! a! rapid! increase! in! CX3CR1! surface! density! on! human! monocytes! and!
significantly! increases!monocyte!adhesion! to! immobilized!CX3CL1!via!activation!of!
the!p38!MAPK!pathway![231].!CX3CL1!stimulation!has!also!been!shown!to!activate!
the!epidermal!growth! factor! receptor! (EGFR)! to!regulate!cell!proliferation! in!human!
vSMCs![222]c!activation!of!CX3CR1!leads!to!the!release!epiregulin,!which!activates!
its! receptor!EGFR! leading! to!PI3K!activation!and!subsequent!Akt!phosphorylation.!
Notably,!PI3K!activation!via!EGFR,!but!not!ERK,! is!essential! for! the!antiRapoptotic!
effect!of!CX3CL1.!PI3K!activation!is!also!required!for!proliferation,!and!without!dual!






The! CX3CL1/CX3CR1! axis! is! known! to! positively! regulate! itself,! as! activation! of!




While!research!has! implicated!a!detrimental! role! for!CX3CL1/CX3CR1!signalling! in!
the! pathophysiology! of! myocardial! I/R,! no! treatments! specific! for! the!
CX3CL1/CX3CR1!axis!have!been!translated!into!clinical!use!due!to!the!inadequate!































































The! signalling! pathways! that! are! activated! downstream! of! CX3CR1! are! poorly!
understood,! however! a! range! of! pathways! have! been! shown! to! be! activated! in!
response! to! CX3CL1.! Inhibition! of! apoptosis! is! the! most! established! function!




Intracellular! Ca++! signalling! is! mediated! by! CX3CR1! activation! which! can!











The! NF!B! Signalling! pathway! is! divided! into! two!main! pathways! known! as! the! i)!
canonical!(classical)!pathway!and!ii)!nonRcanonical!(alternative)!pathway.!These!two!
pathways! have! different! mechanisms! of! signalling,! however! are! both! crucial! for!
regulating!immune!and!inflammatory!responses![233R235].!A!diverse!range!of!soluble!
and! membraneRbound! extracellular! ligands! activate! the! NFκB! canonical! pathway,!
including! ligands! of! various! cytokine! receptors,! PRRs! [236,! 237]! ,! TNF! receptor!
superfamily!members,!TRcell!receptor!(TCR)!and!BRcell!receptor!(BCR)s![25,!238,!239].!




adhesion! molecules,! antimicrobial! factors,! cell! cycle! regulators,! and! cell! survival!
factors.!This!NF!B!regulation!of!gene!expression!occurs!in!a!stimulusR!and!cell!typeR
specific! manner,! leading! to! the! finely! tuned! regulation! of! only! a! subset! of! NF!BR
responsive!genes.!!
!
The! nonRcanonical! ‘alternative’! NF!B! pathway! is! activated! by! immunomodulatory!
factors!including!the!TNFRfamily!cytokines,!lymphotoxin!β!(TNFSF3)![243,!244],!CD40!
ligand! (CD40L!and!TNFSF5)! [243],!B!cell!activating! factor! (BAFF!and!TNFSF13B)!





In! addition! to! its! primary! function! as! an! inducible! transcription! factor,! NF!B! also!
controls!the!expression!of!other!transcription!factors,!highlighting!its!importance!in!the!







While! NF!B! can! engage! in! direct! transcriptional! induction! of! proRinflammatory!
cytokines,! chemokines,! and! inflammatory! mediators! in! a! range! of! different! innate!
immune!cells,!its!activation!can!also!induce!inflammation!through!indirect!mechanisms!
such!as!promoting!the!activation,!differentiation,!and!effector!function!of!inflammatory!
TRcells! [251R253],! and! promoting! M1! inflammatory! macrophage! polarization! [254].!
NFκB! also! has! a! role! in! regulating! the! activation! of! inflammasomes! [255].! NF!B!
therefore!represents!a!complex,!tightly!regulated!signalling!pathway!whose!aberrant!
activation!underlines!a!wide!range!of!chronic!inflammatory!diseases![25,!250,!256].!





The!work! described! in! this! thesis! focuses! on! activation! of! the! canonical,! classical!
pathway!of!NF!B!signalling,!therefore!the!details!of!this!pathway!are!described!herein.!





the! NF!B! subunits! thus! preventing! its! transfer! to! the! nucleus.! In! this! classical!
canonical! signalling! pathway,! a! specific! stimulus! transduces! a! signal! to! a! protein!
kinase,! namely! transforming! growth! factor! betaRactivated! kinase! 1! (TAK1),! which!
subsequently! induces! phosphorylation! of! the! downstream! IKK! complex.! The! IKK!
complex! is! composed! of! two! catalytic! subunits,! IKK"! and! IKK#,! and! a! regulatory!
subunit!known!as!NFκB!essential!modulator!(NEMO)!(or!IKK$)![258].!TAK1Rinduced!
phosphorylation! of! the! IKK! complex! typically! occurs! on! the! IKK#! subunit,! which!
subsequently!stimulates!phosphorylation!of!I!B.!IKK!phosphorylates!the!I!B"!subunit!
at!two!NRterminal!serine!residues!which!triggers!ubiquitinRdependent!degradation!of!





by! its! I!B! inhibitors! it! can! then! rapidly! translocate! into! the! nucleus! to! regulate!
transcription! of! its! target! genes.! The! NF!B! subunits! p65,! p50! and! cRRel! all! have!
transactivation! domains! (TAD)s! at! their! CRterminus! which! governs! their! ability! to!
regulate!the!expression!of!target!genes.!!
!
A! range! of! different! stimuli! can! activate! this! canonical! NF!B! pathway,! including!
cytokines,! growth! factors,! mitogens,! stress! mediators,! and! bacterial! components.!
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Activation!of! the! canonical! ‘classical’!NF!B!pathway! controls! the! transcription!of! a!
plethora!of!genes!in!response!to!a!diverse!range!of!stimuli.!!The!NF!B!subunit!dimers!
p65!and!p50!are!sequestered! in! the!cytoplasm!by! the! inhibitor! I!B"!during! resting!
state.! In! the! presence!of! a! stimulus! such!as!TNFR",! a! signal! is! transduced! to! the!
tyrosine!kinase!TAK1!which!subsequently!induces!phosphorylation!of!the!IKK#!subunit!
of! the! IKK! complex.! Activated! IKK#! phosphorylates! I!B"! leading! to! its! ubiquitinR













diseases,! and! has! proven! to! have! a! key! role! in! cardiac! I/R! [263].! NFκB! targets!
inflammation!not!only!directly!by!increasing!the!production!of!inflammatory!cytokines,!
chemokines! and! adhesion! molecules,! but! also! by! regulating! cell! proliferation,!






significantly! reduced! infarct! size,! therefore! suggesting! that! NF!B! activation! may!










to!50%!of! the!total! infarct!size,!can!be! improved!by! inhibition!of! the!NFκB!pathway!
[267,! 268].! ! Other! agents! that! inhibit! NF!B! signalling! including! sulfasalazine! and!













A! number! of! studies! have! provided! evidence! for! a! relationship! between! the!
CX3CL1/CX3CR1!axis!and!the!NF!B!signalling!pathway.!In!a!recent!study,!Ganga!et!
al!showed!that!CX3CL1! induces!activation!of! the!NF!B!proRinflammatory!signalling!
pathway! through!MSK1! in!microglial! cells! [270].! Knockdown! of!MSK1!with! siRNA!
decreased!MSK1!protein!levels!by!~50%,!which!was!enough!to!decrease!CX3CL1R
induced! mRNA! levels! of! ILR1#,! TNFR"! and! iNOS.! The! absence! of! CX3CR1! also!
impaired!the!mRNA!levels!of!NF!B!p65!genes!regulated!by!this!transcription!factor.!In!
a!mouse!model!of!sepsis,!Raspe!et!al!demonstrated!that!NF!B!can!reverseRregulate!
CX3CL1! and! CX3CR1! during! cecal! ligation! and! punctureRinduced! sepsis! (CLP)R




found! that! CX3CL1! induces! its! own! expression,! which! is! also! mediated! by! the!
PI3K/Akt/NF!B!signalling!pathway![272].!In!hippocampal!neurons,!CX3CL1!induces!
translocation!of!the!NF!B!subunit!p65!into!the!nucleus.!This!process!is!abrogated!by!
a! specific! inhibitor! of! PI3K,! suggesting! that! CX3CL1! activates! NF!B! through! the!
PI3K/Akt!pathway! in!hippocampal!neuronal! cells! [273].! In! intestinal! epithelial! cells,!
CX3CL1!activates!NF!B!and!which! results! in! ILR8!and!CX3CL1!mRNA!expression!
[274].!Activation!of!NF!B!has!also!been!shown!to!be! involved! in!TNFR"!stimulated!
CX3CL1! production! in! vascular! SMCs.! Downregulation! of! p65/NF!B! signals! by!
pertussis!toxin!(PTX)!may!provide!an!explanation!for!the!antiRCX3CL1!effect!of!PTX!
[275].! The! shedding! and! release! of! soluble! astrocytic!CX3CL1! has! also! shown! to!
potentially!involve!the!NF!B!pathway!alongside!ADAM10!protease![276].!Such!studies!
provide! preliminary! evidence! for! the! involvement! of! the! NF!B! pathway! in!
CX3CL1/CX3CR1! signalling.! Further! research! connecting! CX3CL1! to! the! NF!B!
pathway! is! therefore!necessary! to!confirm!and!build!upon! this!existing!knowledge.!














of! the!disease,! there!have!been!discrepancies! in!both! the! temporal! dynamics!and!
function!of!nonRclassical!monocytes!in!the!response!to!cardiac!I/R.!Such!differences!
may!be!due!to!variation!in!the!method!of!defining!these!cells,!or!the!study!of!permanent!











i.! STEMI! patient! circulating! nonRclassical! monocytes! have! distinct! temporal!
dynamics! in! the! acute! postRreperfusion! period,! which! are! associated! with!
subsequent!myocardial!outcomes.!!PreRclinical!mouse!models!show!a!similar!
pattern! of! nonRclassical! monocyte! dynamics! following! cardiac! I/R.!!!
!
ii.! Genetic! knockout! of! the! fractalkine! receptor! CX3CR1! in! a!mouse!model! of!
cardiac! I/R! compromises!monocyte! adhesion! and! infiltration! into! the! injured!
myocardium! which! influences! repair! and! myocardial! function! following! MI.!!
!
iii.! Activation! of! monocyteRexpressed! CX3CR1! by! CX3CL1! binding! induces!











i.! Determine! the! precise! dynamics! of! circulating! monocyte! subpopulations! in!
STEMI!and!NSTEMI!patients!at!time!points!from!ischemia!to!24h!postRPCI!by!
FACS!analysis,!and!investigate!their!relationship!with!STEMI!infarct!size!and!
LVEF.! Quantify! mouse! monocyte! subpopulations! at! similar! time! points!
following!cardiac!I/R!to!identify!interRspecies!similarity!in!monocyte!dynamics.!
!
ii.! Investigate! adhesion! and! recruitment! of! monocyte! subpopulations! into! the!
injured!myocardium!following!cardiac!I/R!by!using!immunofluorescent!staining!
to!quantify!myocardial!postRcapillary!venule!endothelial!monocyte!adhesion!and!
monocyte! infiltration! in! the! infarct! region! at! 2h,! 24h,! and! day! 3! postRI/R.!
Determine! the! effect! of! CX3CR1! knockout! by! comparing! CX3CR1+/+,!




and! regulation! of! downstream! target! genes! ILR1#,! ILR6,! ILR8! and! IκBα.!!
!


















Analysis! of! previously! obtained! FACS! data! (courtesy! of! Dr.! Stephen! Boag! and!
Professor! Ioakim!Spyridopoulos)!was!used! to!quantify!monocyte!subpopulations! in!
the!blood!of!53!STEMI!patients!presenting!with!acute!STEMI!to!the!Freeman!Hospital,!
Newcastle!upon!Tyne,!at! the! time!of!PPCI! for!acute!MI,!and!at!15,!30,!90!minutes!
(arterial! blood)! and! 24! hours! (venous! blood)! postRreperfusion.! In! a! subset! of! 23!
patients,!a!follow!up!venous!blood!sample!was!collected!at!3R6months.!The!original!
study!was!designed!to!analyse!lymphocyte!responses!in!STEMI!patients!(Boag!et!al!








patient! infarct! size! and! MVO! were! assessed! using! cardiac! MRI! 1R8! days! postR






















Onset! of! chest! pain! within! 6!
hours! with! new! ST! segment!







Chronic! inflammatory! conditions! requiring!
treatment!with!immunosuppressive!agents!
!
PreRexisting! contraindications! to! cardiac! MRI!





Infarction! (TIMI)! grade! 2! or! 3! flow)! in! infarct!
related!artery!on!initial!angiography!
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then! removed! using! CD3RFITC! (clone! UCHRT1,! #555332,! BD! Biosciences),! and!
CD56–PerCPReFluor710! (clone! CMSSB,! #42R0567R42,! eBioscience),! respectively.!
Monocyte! subsets! were! then! defined! using! CD16RPE! (clone! B73.1,! #561313,! BD!




































was! acquired! at! the! start! of! the! procedure,! then! at! 90! and! 180!minutes! following!
reperfusion! (Figure!3.1).!Arterial!blood!was!collected! from! the!aorta,! right!coronary!
artery!(RCA)!and!left!coronary!artery!(LCA)!to!compare!monocyte!dynamics!between!
preRreperfusion! vasculatures.! Venous! blood! was! obtained! at! 24! hours.! Ethical!
approval!for!this!prospective!study!was!obtained!from!the!National!Research!Ethics!












































































of! total! monocytes! were! determined! by! the! clear! forward/side! scatter! gate! of!
monocytes!and!TruCount!beads!(BD!Biosciences,!#340334).!!
!






of! the! following! antibodies! (5μl! of! each! antibody):! CD14RBV510! (clone! M5E2,!
#301842),! CD16RAPCRH7! (clone! 3G8,! #560715,! BD!Biosciences),! HLARDRRBV421!
(clone! L243,! #307636),! CD3RFITC! (clone! UCHT1,! #300406),! CD19RFITC! (clone!
HIB19,! #302206),! CD56RFITC! (clone! HCD56,! #318304),! CCR2RPERCy7! (clone!
K036C2,! #357212),! CX3CR1RAPC! (clone! 2A9R1,! #341610).! All! antibodies! were!
supplied! from!BioLegend! unless! stated! otherwise! (Table! 3.6).! Samples!were! then!
lysed!using!Pharm!Lyse!solution!(BD!Biosciences)!diluted!1/10!in!dH2O!for!15!minutes!
at!RT,! followed!by! two!wash!steps!using!a!BD!Lyse!Wash!Assistant!machine! (BD!
Biosciences).!Analysis!was!performed!using!a!BD!LSRFortessa!machine!with!FCS!
Express! 6/7! De! Novo! Software.! Manual! compensation! was! performed! using!
compensation! beads! (UltraComp! eBeads,! #01R2222R41,! Invitrogen).! One! drop! of!
eBeads!was!added!to!a!3μl!sample!of!each!individual!antibody.!Unstained!whole!blood!




intermediate,! and! nonRclassical! monocyte! subset! classification! was! performed! as!
illustrated!in!Figure!4.8.!The!cell!count!for!each!subset!was!calculated!as!the!count!of!















Dr.! David!Grainger! (University! of!Manchester),! with! permission! from!Steffen! Jung!
[277].! In! this! mouse! line,! the! EGFP! gene! replaces! the! first! 390bp! of! the! second!
CX3CR1!exon!encoding!the!N!terminus!of!the!sevenRtransmembrane!receptor!shown!
to! be! crucial! for! interaction!with!CX3CL1.!Heterozygous!CX3CR1+/EGFP!mice! have!























Scientific),! 0.25μl! of! each! forward!and! reverse!primer! (20μM),! 0.5μl! 10mM!dNTPs!
(New!England!Biolabs),!2μl! template!DNA!and!dH2O!made!up! to!a! final!volume!of!
10μl.!All!primers!used!for!genotyping!are!listed!in!Table!3.2.!For!each!PCR,!a!negative!
(dH2O)!and!positive!control!(animal!confirmed!positive)!was!included.!PCR!reactions!













in! an! electrophoresis! tank! and! fully! immersed! in! 1xTAE! buffer! (section! 3.3.5).! A!
volume!of!9μl!of!each!PCR!product!was!then!loaded!into!the!wells.!A!1kb!DNA!ladder!
(Invitrogen)! was! also! loaded! alongside! the! samples! to! allow! assessment! of! PCR!
product!size.!The!loaded!gel!was!left!to!run!at!approximately!80volts!for!60!minutes.!























































































Acute! myocardial! infarction! was! induced! in! adult! male! C57BL/6! mice,! Cx3cr1+/+,!
Cx3cr1+/GFP! and! Cx3cr1GFP/GFP! mice! (12R14! weeks! of! age)! by! an! experienced!
microsurgeon!(Dr.!Rachael!Redgrave).!Mice!were!anaesthetised!using!isoflurane!(3%!
isoflurane/97%! oxygen)! and! general! anaesthesia! was! maintained! throughout! the!
surgery!using!mechanical!ventilation!following!endotracheal!intubation.!Under!sterile!
conditions,!leftRside!thoracotomy!was!performed!through!the!fourth!intercostal!space!
and! the! left! anterior!descending!coronary!artery! (LAD)!was! identified! running! from!




create!a! transient! infarction.!Myocardial! ischemia!was!verified!by!visible! immediate!
blanching! of! the! left! ventricular!myocardium.! The! chest! wall! was! then! temporarily!
closed!and!reopened!after!60!minutes!of!ischaemia,!followed!by!removal!of!PE!tubing!
from! the! suture! to! allow! reperfusion! of! the! LAD.! ShamRoperated! mice! underwent!









Hearts! were! dissected,! washed! in! PBS! to! remove! blood! clots! from! the! ventricle!
chambers!and!subsequently!placed!in!a!light!fixative!of!0.2%!or!1%!paraformaldehyde!
overnight! at! 4°C.! Following! fixation,! hearts! were! transferred! into! a! 30%! sucrose!
solution! and! left! at! 4°C!overnight.!Hearts!were! then!embedded! in!Optimal!Cutting!
Temperature!compound! (OCT)! for!30!minutes!on!dry! ice!and!stored!at! R80°C!until!
required.!Tissue!blocks!were!equilibrated!to!approximately!R20°C!for!30mins!prior!to!




































































































































































washes,! coverslips!were!mounted! using! Prolong!Gold! antifade! reagent! with!DAPI!
(ThermoFisher!Scientific)! and! left! at! 4°C!overnight! in! the!dark.!Data!was!acquired!
using!M2!Axio!Imager!(Zeiss).!Images!were!taken!at!x5,!x20!and!x40!magnification!






























































region! (dotted! white! line)! that! were! considered! representative! of! the! infarct! were!
imaged!per! section.!For!each!FOV,!an! image!was! taken!at! x40!magnification!and!
CD45+!DAPI! (nucleated)! cells!were!manually! counted! on!Zen! 2.3! software.! Three!
sections! per! heart! were! analysed! and! used! to! calculate! an! average! number! of!
leukocytes!within!the!infarcted!and!remote!regions.!The!same!technique!was!applied!















20R40μl! tailRvein! murine! peripheral! blood! was! collected! into! EDTA! tubes! (Teklab,!
#K100PP).!Samples!were!incubated!with!Fc!block!(1/10!dilution)!for!10!minutes!at!RT.!
Samples!were!incubated!with!antibodies!against!CD11b,!CD115,!Ly6G,!LY6C,!CCR2,!
and!CX3CR1! (Table! 3.7)! for! 30!minutes! at!RT! in! the! dark.! 1ml! of! BD!Pharmlyse!
solution!(1/10! in!dH2O)!was!added!to!each!sample,!briefly!vortexed,!and!left! for!15!





















































were! then!washed! in!200µl!FACS!buffer!and!centrifuged!at!1000g! for!60!seconds.!
Supernatant!was!discarded!and!samples!were!reRsuspended!in!200μl!FACS!buffer.!
Cells!were! then! filtered!using!30!µm!CellTrics! filters.!100μl!of!cell!suspension!was!
used!per!sample.!Samples!were!incubated!in!50μl!Fc!block!(BioLegend,!#101302)!for!
10!minutes!at!RT!followed!by!incubation!in!a!cocktail!of!antibodies!(CD11b!CD45!Ly6C!

























































The! THPR1! human! monocytic! cell! line! is! an! immortalizedRmonocyteRlike! cell! line!
derived!from!the!peripheral!blood!of!a!childhood!case!of!acute!monocytic! leukemia!
(M5!subtype)![278].!THPR1!cells!represent!a!valuable!tool!for!researching!monocyte!
function! in! both! health! and! disease.! All! procedures!were! carried! out! under! sterile!
conditions!in!a!tissue!culture!hood.!THPR1!monocytes!were!cultured!at!a!density!of!1R
5x105cells/ml! in! RPMI! 1640! Dulbecco’s! modified! Eagle's! medium! (DMEM)!
supplemented!with!5%!heat! inactivated! fetal!calf!serum!(FCS)!and!0.5%!PenicillinR
Streptomycin!(P/S),!at!37oC.!The!medium!was!replaced!every!2R3!days.!The!Mono!
Mac! 6! (MM6)! cell! line! is! established! from! the! peripheral! blood! of! a! patient! with!
monoblastic!leukemia![279].!MM6!monocytes!were!cultured!at!the!same!density!and!
in!the!same!conditions!as!THPR1!cells!and!the!medium!was!replaced!every!2R3!days.!
U937! is! a! proRmonocytic,! human! myeloid! leukaemia! cell! line! isolated! from! the!
histiocytic!lymphoma!of!a!37RyearRold!male![280].!U937!cells!metabolize!faster!than!





























ratio! was! above! 1.9! and! the! A260/A230! was! between! 1.8R2.2! (if! either! ratio! is!






















polymerase! (Applied! Biosystems),! 1μl! 20mM! dNTPs! (New! England! Biolabs),! 1μl!










































Gene$ Assay$ID$ Cat$no.$ Company$
GAPDH! Hs02786624! 4331182! Applied!Biosystems!
RPL13A! Hs03043885_g1! 4331182! Applied!Biosystems!
ILR6! Hs00174131_m1! 4331182! Applied!Biosystems!
ILR8! Hs00174103_m1! 4331182! Applied!Biosystems!
I!B"! Hs00153283_m1! 4331182! Applied!Biosystems!

































































4%! Marvel/TBST.! The! membranes! were! then! incubated! with! the! appropriate!
secondary!antibody!directed!against!the!primary!antibody’s!species!of!origin!(Table!



























































EDTA! antiRcoagulated! blood! was! obtained! from! healthy! volunteers! after! informed!
consent!and!in!accordance!with!the!ethical!guidelines!of!the!institution.!PBMCs!were!
firstly! removed! by! centrifugation! of! whole! blood! over! Histopaque! (Sigma! Aldrich,!
#10771),!followed!by!erythrocyte!lysis!using!Lysing!Buffer!(BD!Pharm!Lyse,!#555899).!
PBMCs! were! then! subject! to! monocyte! negative! selection! using! the! Monocyte!
Isolation!Kit!II!and!manual!columns!(Miltenyi!Biotec,!#130R042R201),!strictly!according!
to!the!manufacturer's!protocol.!The! isolation!of!viable!monocytes!was!evaluated!by!
trypan! blue! staining! and!manual! counting! using! a! haemocytometer.! The! purity! of!





































assessed! using! Spearman! correlation! coefficient.! Data! are! expressed! as! mean! ±!
standard!error!of!the!mean!(SEM)!except!where!otherwise!stated.!A!p!value!of!less!





The!prospective!STEMI! patient! study!was!approved!by! the! local! ethics! committee!
(REC!reference:!16/NE/0405),!and!was!conducted!according!to!the!principles!set!out!

































Anti9Human&Antibody& Fluorochrome& Clone& Company& Cat&No.&
CD16! APC)H7! 3G8! BD!Biosciences! 560715!
CD14! BV510! M5E2! BioLegend! 301842!
CCR2! PE)Cy7! K036C2! BioLegend! 357212!
CX3CR1! APC! 2A9)1! BioLegend! 341609!
HLA)DR! BV421! L243! BioLegend! 307635!
CD3! FITC! UCHT1! BioLegend! 300406!
CD19! FITC! HIB19! BioLegend! 302206!








Anti9Mouse&Antibody& Fluorochrome& Clone& Company& Cat#&
CD11b! APC! M1/70! BioLegend! 101211!
Ly6C! PE! HK1.4! BioLegend! 128007!
CX3CR1! BV421! SA011F11! BioLegend! 149023!
CCR2! PE)Cy7! SA203G11! BioLegend! 150611!
LY6G! PerCP)Cy5.5! 1A8! BioLegend! 127615!
CD115! BV711! AFS98! BioLegend! 135515!
F4/80! BV605! BM8! BioLegend! 123133!
CD45! BV785! 30)F11! BioLegend! 103149!
CD4! BV711! RM4)5! BioLegend! 100549!
CD8a! BV711! 53)6.7! BioLegend! 100747!
CD19! BV711! 6D5! BioLegend! 115555!
NK1.1! BV605! PK136! BioLegend! 108739!
CD11c! BV785! N418! BioLegend! 117335!
Brilliant!Stain!Buffer! ! ! BD! 563794!









Antibody& Species&raised&in& Concentration& Vendor& Cat&No.&
Primary!Antibodies!
Anti)mouse!CD45! Rat! 1/100! BioLegend! 103102!
Anti)mouse!CD11b! Rat! 1/100! BD!Pharminogen! 553308!
Anti)mouse!GFP! Chicken! 1/300! Abcam! ab13970!
Anti)mouse!CCR2! Rabbit! 1/50! Abcam! ab203128!
Alexa!Fluor!647!Anti)mouse!F4/80!
Antibody!
Rat! 1/100! BioLegend! 123121!
Anti)mouse!CD68! Rat! 1/100! ABD!Serotec! MCA1957GA!
Secondary!Antibodies!
Anti)rat!Alexa)488! Goat! 1/200! Life!Technologies! A11006!
Anti)chicken!Alexa)568! Goat! 1/200! Life!Technologies! A11041!














































































concept! that! MI! leads! to! an! acute! inflammatory! response,! which! is! mediated! by!
classical!monocytes! from!day!1D4!postDMI,! and! is! subsequently! followed!by!a!proD
fibrotic!reparative!response!dominated!by!nonDclassical!monocytes!from!day!5D9!postD
MI![158,!281]!(see!section!1.3.5).! Importantly,!a!perturbation!of!either!phase!during!
the!biphasic!monocyte! response!has!been!shown! to! severely! compromise!cardiac!
repair!in!a!parabolic!mannerJ!if!inflammatory!classical!monocytes!persist!too!long!in!
the! infarct,! the! reparative! functions!of!nonDclassical!monocytes,!myofibroblasts!and!
endothelial! cells! are! impaired,! however! if! the! infarct! recruits! insufficient! classical!
monocytes,!wound!healing!is!delayed!since!debris!cannot!be!cleared!efficiently!and!








traditional! preclinical! models! of! MI! which! study! the! monocyte! response! following!
unreperfused! MI,! in! contrast! to! postDischemia! reperfusion.! Although,! more!







Among! the! small! number!of! studies!published! to!date,! there!has!been!a! focus!on!
monocyte!subpopulation!dynamics!following!MI!at!time!points!ranging!from!day!1!to!7!
following!reperfusion![170D175,!283].!Monocyte!subpopulations!in!the!blood!have!been!
shown! to!specifically! respond! to! the!extent!of!cardiac! injury! following!MI,!and!may!
therefore! offer! reliable! biomarkers! to! prioritize! patients! for! follow! up!
treatments/management.!However,!the!reported!associations!are!varied!and!in!some!
cases!contradictory! (see!Chapter!1! section!1.3.6).!The!precise! link!between!blood!
levels!of!monocyte!subpopulations!and!STEMI!patient!cardiac!outcome!is!therefore!
yet!to!be!determined.!Moreover,!the!earliest!time!point!studied!among!those!published!
is! day! 1! postDreperfusion.!As! such,! current! literature! has!not! addressed!monocyte!
subset!dynamics!within!the!first!immediate!24h!following!reperfusion,!which!represents!
a! critical! time! point! to! intervene,! and! is! prior! to! patient! discharge.! In! this! study,! I!
therefore!investigated!monocyte!dynamics!at!time!points!within!the!first!24h!following!
by!PPCI,!during! the!very! immediate!acute!phase! following! reperfusion.!To!achieve!




patients! received! a! cardiac!MRI! therefore!monocyte! dynamics! could! be! assessed!
against!markers!of!myocardial! injury!(infarct!sizeJ!IS!and!microvascular!obstructionJ!
MVO)!or!myocardial!function!(left!ventricular!ejection!fractionJ!LVEF).!In!a!subset!of!
STEMI! patients! (n=20),! 3Dmonth! follow! up! samples! were! also! collected.! NSTEMI!
patients!(n=15)!were!recruited!as!a!control!population!in!this!study,!as!this!allows!the!
study! of! MI! without! the! sudden! ischemia! and! intense! inflammatory! cascade! that!














was! due! to! their! known! high! expression! of! CX3CR1,! compared! to! classical! and!
intermediate! monocytes! which! express! low! and! medium! levels! of! the! fractalkine!
receptor,!respectively.!In!both!mouse!and!human,!numerous!studies!have!now!linked!
the!CX3CL1/CX3CR1!axis! to!postDreperfusion!cardiac!repair! [210,!287D291].! In! this!
chapter,! I! therefore!hypothesised! that!circulating!CX3CR1hi!nonDclassical!monocyte!





























Human! circulating! classical,! intermediate,! and! nonDclassical!monocyte! populations!
were! defined! by! FACS!analysis! as! shown! in! Figure! 4.1! (details! in! section! 3.1).! A!
database! of! patient! clinical! parameters! is! described! in! Table! 4.1.! Retrospective!
analysis! of! STEMI! and! NSTEMI! patient! blood! samples! at! time! points! from! preD
reperfusion! to! 24h! postDPCI! revealed! distinct! temporal! dynamics! of! monocyte!
subpopulations! following! PPCI! (Figure! 4.2A).! STEMI! patient! circulating! CD16D!
classical!monocyte!counts!dropped!in!the!circulation!from!baseline!to!90!minutes!postD
reperfusion! by! 16%! (p=0.023).! This! was! followed! by! a! sharp! recovery! in! CD16D!
classical!monocytes!at!24h!postDPCI! (p<0.0001)! from!90min!by!46%,! increasing! to!
and! surpassing! preDreperfusion! baseline! counts.!When! comparing! CD16D! classical!
monocyte!dynamics!between!ACS,!there!were!no!significant!differences!in!classical!
monocyte! counts! between! STEMI! and!NSTEMI! patients! at! any! of! the! time! points!
studied! (Table!4.2).!The!dynamics!of! intermediate!monocytes! following! reperfusion!
followed!a!similar!pattern!to!that!of!classical!monocytesJ!CD16+!intermediate!monocyte!
counts!decreased! in! the!circulation!from!preDPCI! to!90!minutes!postDreperfusion!by!



























































Age! 59.3!±!10.7! 61.1!±!11.8! 0.742! 58.9!±!10.5!
Male!(%)! 44!(74.6)! 11!(73.3)! 1.000! 10!(76.9)!
BMI! 26.8!±!4.6! 30.9!±!6.0! 0.006! 28.9!±!6.6!
Diabetes!(%)! 6!(10.2)! 0!(0)! 0.337! 1!(7.7)!
Active!smoker!(%)! 31!(52.5)! 4!(26.7)! 0.089! 6!(46.2)!
Hypertension!(%)! 19!(32.2)! 10!(66.7)! 0.020! 6!(46.2)!
Anterior!MI!(%)! 28!(47.5)! N/A! N/A! 10!(76.9)!




26.8!±!14.3! N/A! N/A! 27.4!±!13.7!
OnsetDtoDreperfusion!
time!(minutes)!
164.6!±!81.3! N/A! N/A! 151.9!±!81.4!
PreDPCI! flow! (TIMI!
0/1/2/3)!
55/4/0/0! 2/1/0/12! <0.001! 13/0/0/0/!
Post! PCI! flow! (TIMI!
0/1/2/3)!
0/0/0/59! 1/0/0/14! 0.203! 1/1/1/10!
Vascular! access!
(radial/femoral)!










































































































































































































immediately! following! reperfusion! to! 24h!postDPCI.!STEMI! patient! classical!CD16D,!
intermediate!CD16+,!and!nonDclassical!CD16++!monocyte!subpopulations!show!acute!
changes! in!cell!counts!over! time.!The!most!dramatic!change! is! the!drop! in!CD16++!
nonDclassical!monocytes!from!preDreperfusion!to!90min!post!reperfusion!(p<0.0001).!
Lower!asterisks!indicate!statistical!differences!in!counts!between!indicated!time!points!
in! STEMI! patients! (OneDway! Anova! with! Bonferroni’s! adjustment! for! multiple!
comparisons)J! upper! asterisks! indicate! statistical! differences! between! STEMI! and!






































614±39! 489±32! 67±12! 58±9!
ns!(0.512)! ns!(0.751)! ns!(0.76)!
639±47! 529±35! 71±8! 39±5!
15min!
542±32! 442±26! 54±11! 47±7!
ns!(0.451)! ns!(0.796)! *!(0.014)!
571±42! 487±31! 58±7! 26±4!
30min!
541±35! 437±30! 55±10! 49±7!
ns!(0.567)! ns!(0.861)! **!(0.004)!
549±41! 468±30! 57±7! 24±4!
90min!
564±34! 468±32! 53±7! 43±6!
ns!(0.704)! ns!(0.935)! *!(0.013)!









































investigated! whether! these! dynamics! correlated! with! markers! of! myocardial! injury!









Interestingly! this! analysis! revealed! that! STEMI! patients! with! larger! infarcts! had! a!
greater!depletion!of!circulating!CD16++!nonCclassical!monocytes!during!the!total!acute!
postCreperfusion!period!(preC90min),!than!those!patients!with!small!infarcts!(p=0.039)!




only! observed! between! preCreperfusion! and! 90! min,! and! not! between! other! time!
periods! such! as! 15C30min! postCPCI! (Figure! 4.3B).! Classical! and! intermediate!
monocyte! dynamics! between! preCreperfusion! and! 90min! postCPCI! showed! no!













































Relationship! between! infarct! size! and! A.! total! acute! postCreperfusion! period! (PreC
90min)! and! B.! early! postCreperfusion! changes! (15C30min)! in! classical! CD16C,!
intermediate!CD16+,!and!nonCclassical!monocytes!CD16++!in!STEMI!patients.!STEMI!
patients!underwent!cardiac!MRI! to!detect!and!quantify! infarct!size.!STEMI!patients!
received! cardiac!MRI! between! day! 1C8! following! primary! PCI! and! short! axis! LGE!
images!were!used! to!quantify! infarct! size,!all! of!which!were! taken!at!end!diastole.!
Infarct!size!was!expressed!as!the!percentage!of!left!ventricle.!STEMI!patients!were!




















































































































no! predictive! value! of! classical! or! intermediate! blood! counts! on! this! marker! of!

























all! of! which! were! taken! at! end! diastole.! Regions! of! hypoenhancement! within! the!
















































































































preCreperfusion! to! 90min!was! predictive! of! a! larger! infarct! size! in!STEMI! patients,!















Analysis! of! the! early! acute! reperfusion! period! (15C30min)! identified! a! significant!
association!between!classical!monocyte!blood!counts!and!LVEF!(Figure!4.5B).!During!
this! immediate! time! frame! following! reperfusion,! a! greater! depletion! of! classical!
monocytes! in! the! circulation! was! significantly! correlated! with! a! lower! LVEF! and!
therefore!worsened!systolic!function!in!these!patients!(p=0.017,!r=0.481).!In!contrast!




















planimetry! around! the! endocardial! and! epicardial! borders,! allowing! calculation! of!
chamber!volumes!at!endCsystole!and!endCdiastole!which!were!used!to!calculate!LVEF.!









































































































































Troponin!T! levels!are!a!biomarker! indicative!of!myocardial! necrosis,! and! therefore!
typically! rise! 2C4! hours! following! the! event! of! an!MI! [292].! Peak! troponin! T! levels!
therefore!expectedly! increase!with!STEMI!patient! infarct!size,!which!we!observe! in!
this!study!(p<0.0001)!(Figure!4.6).!
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p = 0.9 (ns)
r = 0.043
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p = 0.743 (ns)
r = -0.086
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In! the! retrospective! STEMI! patient! study,! the! analysis! of! circulating! classical,!
intermediate,! and! non>classical! monocyte! populations! relied! on! using! scatter!
properties!to!define!the!total!monocyte!population!and!CD16!expression!to!define!each!




This! strategy!was! therefore!employed! in!a! subsequent! smaller! prospective!STEMI!
patient!study! (n=13)! (Table!4.1),!whereby!monocytes!were!defined!as!CD3>!CD19>!
CD56>! HLA>DR+.! Monocyte! subpopulations! were! then! further! refined! as! classical!




marker! expression! profile! of! each! blood! monocyte! subset! analysed! in! this! study!
correspond!to!current!nomenclature![293]![294].!Through!the!use!of!this!detailed!panel!
of! leukocyte! markers,! this! gating! strategy! also! allowed! phenotyping! of! CX3CR1!
expression!by!T>cells,!B>cells,!and!NK>cells!(Figure!4.10).!!
!
The! aim! of! this! prospective! study! was! to! confirm! the! circulating! monocyte!













monocyte! counts! significantly! decreased! during! the! acute! post>reperfusion! period!
(pre>90min)! by! 52%! (±6)! (81±11! to! 36±5! cells/µl,! p=0.0008)! (Figure! 4.11).! At! the!
additional!time!point!of!180!minutes’!post>reperfusion,!non>classical!monocyte!counts!







































































































































































































































































































































the! basis! of! CD3,!CD19! and!CD56! expression,! respectively! (Lin+).! HLA>DR+! non>
monocytes!such!as!dendritic!cells!were!excluded!as!CD14>!CD16>!cells.!Expression!of!
monocyte! markers! CD14,! CD16,! CCR2! and! CX3CR1! by! each! monocyte! subset!
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4.2.7' Comparison' of' Retrospective' and' Prospective' STEMI' Patient' Non?
Classical'Monocyte'Dynamics'at'24h'post?PCI'
!
Comparison! between! this! prospective! study! and! the! previously! described!
retrospective!STEMI!patient!study!showed!that!there!is!a!similar!fall!in!circulating!non2
classical! monocytes! between! pre2reperfusion! (baseline)! and! 90! minutes’! post!
reperfusion!(Figure!4.13A).!Specifically,!non2classical!monocytes!are!depleted!from!
baseline! to!90!min!post2reperfusion! in! the! retrospective!study!by!46%!which! is!not!
significantly!different!from!the!52%!drop!observed!in!the!prospective!study.!Classical!
and! intermediate! monocytes! also! show! comparable! dynamics! (from! baseline! to!
90min)!between!studies.!Classical!monocytes!fall!in!the!circulation!by!9%!and!7%!in!




difference! that! was! observed! between! the! two! studies! was! that! non2classical!
monocyte! counts! recover! at! 24! hours! post2reperfusion! in! the! retrospective! study!
(Figure! 4.2A),! while! prospective! STEMI! patients’! non2classical! monocyte! counts!
remain!depleted!in!the!circulation!at!24!hours!(Figure!4.11).!Notably,!this!discrepancy!
between!studies!was!specific! to!CD16++!non2classical!monocytes.!To!examine! this!
























this! limitation! at! the! 24h! time! point,! non2classical! monocyte! dynamics! observed!
between!pre2reperfusion!and!90!minutes!post2PCI!were!concordant!between!studies!


























Retrospective! and! prospective! STEMI! patient! studies! concur,! in! that! there! is! a!
significant! depletion! in! non2classical! monocytes! in! the! circulation! from! pre2PCI! to!



























































































































































































































































































































































CD16++ HLA-DR+ Non-Classical Monocytes 












































the! prospective! data,! with! the! subsequent! use! of! HLA2DR,! CD14! and! CCR2! to!
interrogate! any! observed! differences.! A! small! population! of! HLA2DR2! CD16++!
neutrophils! are! present! within! the! CD16++! non2classical! monocyte! gate! which! are!
responsible! for! the! increase! in! CD16++! population! counts! at! 24h! post2PCI! in! the!






















the! forward! and! side! scatter! of! total! monocytes! (Figure! 4.1),! in! contrast! to! the!
prospective!method!which! included!both!the! lymphocyte!and!monocyte!populations!
(Figure! 4.8).! Examination! of! classical,! intermediate,! and! non2classical! monocyte!
subpopulations!within! the! prospective! total!monocyte! and! lymphocyte! scatter! gate!
revealed! that! the! non2classical! monocytes! have! lower! side! scatter! than! the! other!
monocyte!subsets,!and!therefore!are!situated!closer!to!the!lymphocyte!border!of!the!
monocyte! scatter! population! (Figure! 4.16).! Based! on! this! observation! it! was!
speculated!that!the!retrospective!gating!method!may!have!led!to!the!exclusion!of!a!
small! proportion! of! non2classical! monocytes! due! to! the! gating! cut! off! at! the!
monocyte/lymphocyte! border.! This! technical! difference! between! retrospective! and!
prospective! gating! methods! may! in! part! account! for! the! reduced! counts! of! pre2




patient! cohortsg! it! is! well! published! that! leukocyte! counts! fall! in! the! circulation! in!
response! to! ischemia! following!MI,! the! extent! of! which! is! related! to! the! extent! of!
myocardial! injury.! It! therefore! follows! that! a! larger! infarct!would! induce! a! stronger!






Interestingly,! the! retrospective! STEMI! patient! cohort! was! found! to! have! a! higher!
average! level!of!peak! troponin!T! (4895±530)! than!prospective!patients! (3173±786)!
(Figure!4.17A).!Although!this!difference!was!not!significant,!it!demonstrated!a!similar!
trend!to!the!non2significantly!higher!counts!of!pre2reperfusion!non2classical!monocytes!





size! as! determined! by! higher! peak! troponin! T.! It! therefore! appeared! that! the!
retrospective!cohort!had!a! larger!average! infarct!size! than!prospective!patients,!as!
determined! by! high! Troponin! T! levels,! which! induced! an! earlier! depletion! of! non2
classical!monocytes!in!the!circulation.!Patients!in!the!retrospective!cohort!may!have!
suffered!from!larger!infarct!due!to!the!longer!ischemia!period!observed!in!this!cohortg!















































































































































































































































































































































































A,! D.! Comparison! of! peak! troponin! T! levels! and! onset2to2balloon! times! between!




explain! the! lower!pre2reperfusion!non2classical!monocyte!count! in! the!retrospective!
study!compared!to!the!prospective!study.!C.!No!significant!relationship!between!pre2
reperfusion! non2classical! monocyte! counts! and! peak! troponin! T! levels! in! the!
prospective! study,! though! this! analysis! may! be! underpowered! (n=13).! E,! F.!
Relationship! between! onset2to2balloon! time! (ischemic! period)! and! peak! troponin! T!
levels!in!the!E.!retrospective!study!and!F.!prospective!study.!!In!both!studies,!there!
was! no! significant! correlation! between! onset2to2balloon! time! and! peak! troponin! T!












relied! on! the! markers! CD16! and! CD14! for! monocyte! subset! definition,! though!
populations!of!intermediate!and!non2classical!monocytes!defined!using!this!approach!!
are! frequently! contaminated! [301].! For! example,! one! limitation! of! the! conventional!







determine! monocyte! subpopulation! dynamics! in! disease! [303].! One! approach! to!
minimize!the!inconsistencies!that!arise!from!the!arbitrary!gate!placement!using!CD14!
and!CD16! is! to! combine!multiple! informative! cell! surface!markers.! In! this! study,! I!




contamination.! To! address! this! and! increase! the! specificity! of! monocyte! subset!
identification,!the!chemokine!markers!CCR2!and!CX3CR1!were!included!and!used!in!
combination! to! confirm! monocyte! subset! definitiong! classical! monocytes! CCR2hi!
CX3CR1lo,! intermediate! monocytes! CCR2mid! CX3CR1mid,! non2classical! monocytes!
CCR2lo! CX3CR1hi.! ! This! method! was! reproducible! throughout! the! STEMI! patient!
prospective!study!and!therefore!provides!a!robust,!accurate,!and!sensitive!protocol!for!
human!blood!monocyte!subset!quantification!by!flow!cytometry.!More!recent!studies!
















changes! in!monocyte!kinetics! following!PCI!have!not!been!addressed.!Moreover,! I!
observed! that! NSTEMI! control! group! levels! of! non2classical! monocytes! were!
consistently! higher! than! that! of! STEMI! patients,! at! 15,! 30,! and! 90!minutes’! post2
reperfusion,!and!NSTEMI!patients!did!not!demonstrate!a!significant!depletion!of!non2





of! monocyte! behaviour! following! myocardial! I/R.! The! striking! dynamics! of! non2
classical!monocytes!during!the!acute!post2reperfusion!period!are!largely!confined!to!














The!vast! loss!of! non2classical!monocytes! from! the!circulation! following!cardiac! I/R!
could!indicate!a!number!of!responses!by!these!cells!in!response!to!myocardial!injury.!
It! is!possible! that! following! reperfusion,! these!cells!are!marginated! to! the!coronary!
endothelium,!prior!to!their!extravasation!into!the!myocardial!tissue!to!facilitate!repair,!
leading!to!a!decrease!in!circulating!counts.!As!previously!described!in!Chapter!1,!this!
process! is! largely!mediated!by! the!CX3CL1/CX3CR1!axisg! the! release!of!CX3CL1!
following!myocardial!injury!governs!the!chemoattraction!of!non2classical!monocytes!to!
the!injured!myocardial!tissue,!while!upregulation!of!vascular!endothelium2expressed!








into! the!heart! that!are! lost! from! the!circulation!during! the!acute2reperfusion!period,!
may!contribute!to!inflammation!and!potentially!tissue!damage!at!their!destination!in!
the!myocardium!following!cardiac!I/R.!Assuming!the!occurrence!of!this!scenario,!the!





may! be! related! to! the! inflammatory! potential! of! non2classical! monocytes.! Recent!
reports! have! described! that! upon! activation,! non2classical! monocytes! are! the!
dominant!inflammatory!subset!over!classical!monocytes,!and!produce!high!levels!of!
inflammatory! cytokines! TNF2 ! and! IL21 ! in! response! to! a! range! of! stimuli!
predominantly! via! TLR! signalling! [154,! 1642166].! Furthermore,! non2classical!
monocytes! have! recently! been! shown! to! express! high! levels! of! costimulatory!
molecules!HLA2DR,!CD80,!CD86,!and!may!therefore!contribute!to! inflammation!via!
CD402mediated! T2cell! activation! [167].! Through! these! potential! mechanisms,! it! is!




reperfusion! could! lead! to! exaggerated! infiltration! of! these! cells! into! the! injured!
myocardium!which!may!in!turn!exacerbate!the!inflammatory!response!to!cardiac!I/R!
and! compromise! heart! tissue! repair.! In! support! of! this! idea,! treatment! with! anti2
CX3CL1!antibody!in!a!mouse!model!of!cardiac!I/R!mice!lead!to!smaller!infarct!size,!
potentially! due! to! reduced! Ly6Clo! non2classical! monocyte! infiltration! into! the!
myocardium![203].!It!is!however!necessary!to!consider!the!correlational!nature!of!the!






intermediate!monocyte! dynamics! at! day! 1,! 3! and! 7! following! reperfusion! however!













monocytes! (~day! 5),! were! significantly! higher! in! patients! with!MVO! than! in! those!
without!MVO![307].!!!
!
A! final! parameter,! LVEF,! was! assessed! in! STEMI! patients! against! non2classical!
monocyte!post2reperfusion!dynamics.!LVEF! is!a!central!measure!of! left! ventricular!
systolic!function,!and!therefore!has!prognostic!value!in!predicting!adverse!outcomes!














be! a! potential! source! of! error! for! the! association! observed! between! non2classical!
monocyte!dynamics!with!LVEF,!but!not!infarct!size.!A!study!of!monocyte!dynamics!at!
day! 1,! 3! and! 7! post2reperfusion! has! however! demonstrated! that! a! progressive!








and! prospective! cohorts! described! in! this! thesis! were! investigated! by! addressing!




can! be! upregulated! by! IFN2!! stimulation! [308],! CD14! is! weakly! expressed! by!
neutrophils! [309],!and!chronic! inflammation!can! induce! the!expression!of!CCR2!by!
neutrophils! [310,! 311].! The! increased! count! of! non2classical! monocytes! at! pre2
reperfusion! in! the! prospective! study! compared! with! the! retrospective! study! was!
explained! by! both! potential! technical! and! biological! factorsg! exclusion! of! the!
lymphocyte!population!in!the!retrospective!gating!method!may!have!underestimated!









STEMI! patients! following! reperfusion! are! associated! in! some!way,! with! long! term!
cardiac! function! and! patient! prognosis.!Direct! intervention! to!modify! the!monocyte!
response!early!after!STEMI!may!therefore!have!favourable!effects!on!the!inflammatory!
and! reparative!phases!of! infarct! healing.!The!distinct!CX3CL1/CX3CR12dependent!
recruitment! mechanism! of! non2classical! monocytes! offers! a! reasonable! target! to!
control!the!number!of!non2classical!monocytes!to!the!infarct.!Currently!there!remains!
no!approved! targeted! therapy! to! reduce! cardiac! I/R! injury! in!STEMI!patients.!This!
potential!intervention!however!would!offer!the!opportunity!to!therapeutically!intervene!










potential! existence! of! a! mechanistic! link! between! early! non2classical! monocyte!






















monocytes! are! distinct! from! their! classical! and! intermediate! monocyte! subset!
counterparts! partly! through! their! high! expression! of! CX3CR1,! which! raises! the!




described! that! non2classical! monocytes! arrive! in! the! injured! myocardium! at!
approximately!day!5!following!I/R!and!peak!at!day!7![281],!however!this!theory!has!
since! been! disproved! as! it! has! been! shown! that! classical! monocytes! undergo! a!
phenotypic!shift!into!non2classical!monocytes!rather!than!a!subsequent!second!influx!
of!these!cells.!Yan!et!al!demonstrated!that!reperfusion!45!minutes!after!MI!changes!
the! timing!of! immune!cell! influx! into! the! infarct!myocardium!to!an!earlier! time!point!
compared!with!permanent!MI,!whereby!the!macrophage!infiltration!shifts!from!day!7!




inflammatory! signal! [313].! More! refined! gating! strategies! and! lineage! tracing!
experiments!have!identified!these!Ly6Clo!monocytes!as!Ly26Clo!macrophages,!which!










vascular! endothelium2expressed! transmembrane! CX3CL1! is! cleaved! into! soluble!
CX3CL1! in! response! to! myocardial! damage! and! inflammatory! stimuli! [197].! As! a!
result,! non2classical!monocytes!will! no! longer! demonstrate! patrolling! behaviour! as!
witnessed!in!the!resting!state![125],!but!can!migrate!more!readily!to!the!heart!tissue.!
In!order!to!investigate!monocyte!recruitment!to!the!injured!heart!tissue!in!this!study,!a!
mouse!model!of! cardiac! ischemia2reperfusion! (I/R)!was!used! (described! in!section!
3.4).! This! model! permits! the! study! of! immune! cell! infiltration! into! the! injured!
myocardium!at!specified!time!points!following!cardiac!I/R,!using!two!methodological!
approachesg!1)!immunofluorescence!staining!of!the!heart!tissue!(section!3.5,!3.6),!and!
2),! enzymatic! digestion! of! the! heart! tissue! and! FACS! analysis! (section! 3.9.3).!
Monocyte! subpopulations! were! also! studied! in! the! circulation,! spleen,! and! bone!




To! investigate! the! importance! of! monocyte2expressed! CX3CR1! in! monocyte!
recruitment,!adhesion,!and!infiltration!into!the!injured!heart!tissue!post2cardiac!I/R,!a!
transgenic!CX3CR12GFP!mouse!line!was!used!(section!3.3.1),!in!which!an!essential!
part!of! the!Cx3cr1!gene! is! replaced!by!EGFP! [277].!These!mice!express!EGFP! in!
monocytes,! dendritic! cells,! NK! cells,! and! brain! microglia! under! control! of! the!
endogenous! Cx3cr1! locus.! This! line! was! used! to! compare! the! post2cardiac! I/R!
monocyte! response! between! Cx3cr1+/+,! Cx3cr1+/GFP,! and! complete! knockout!
Cx3cr1GFP/GFP!mice.!
!







Ly6Chi! monocytes! resemble! CD14++CD162! classical! monocytes,! while! Ly6Clo!
monocytes! resemble! CD14+CD16++! non2classical! monocytes! [3182321].! An!
intermediate! population! also! exists! in! mice,! as! in! humans.! The! effect! of! genetic!
CX3CR1!ablation!on!Ly6Clo!non2classical!monocyte!dynamics!post2I/R!was!evaluated!










analysis! showed! a! ~50%! loss! of! CX3CR1! gene! expression! in! Cx3cr1+/GFP! mice!
compared! to! WT! animals,! and! 100%! loss! of! CX3CR1! gene! expression! in!
















mice! show! 50%! CX3CR1! transcript! compared! with! WT,! and! practically! 0%! in!












5.2.2' Mouse' Baseline' Circulating' Classical,' Intermediate' and' Non?Classical'
Monocyte' Subpopulation' Dynamics' and' the' Effect' of' Genetic' CX3CR1'
Knockout.'' '
!
Baseline! peripheral! blood! Ly6Chi! classical,! Ly6Cinter! intermediate,! and! Ly6Clo! non2
classical! monocyte! counts! were! first! quantified! across!Cx3cr1+/+,!Cx3cr1+/GFP! and!
Cx3cr1GFP/GFP! mice! to! determine! any! pre2existing! differences! in! monocyte!
subpopulations!due!to!genetic!depletion!of!CX3CR1.!Peripheral!blood!samples!were!
collected! from!mouse! tail!vein!and!analysed!by!FACS!as!described! in!section!3.8.!
Monocyte!subpopulations!were!defined!as!classical![CD11b+!CD115+!LY6G2!LY6Chi!





This! initial! analysis! showed! that! baseline! counts! of! the! Ly6Chi! classical!monocyte!
population! were! not! significantly! different! between! Cx3cr1+/+,! Cx3cr1+/GFP! and!




counts! were! significantly! reduced! in!Cx3cr1GFP/GFP!mice! (96(±17)/μl),! being! 47.5%!







































































































































































































































































Baseline! TruCount! of! circulating! classical! [CD11b+CD115+LY6G>LY6Chi!
CCR2hiCX3CR1mid>hi],! intermediate! [CD11b+CD115+LY6G>LY6Cinter!
CCR2midCX3CR1mid>hi],! and! non>classical! [CD11b+CD115+LY6G>LY6CloCCR2lo!





































































































5.2.3' Mouse' Circulating' Classical,' Intermediate' and' NonDClassical' Monocyte'
Dynamics' at' 2h' and' 24h'PostDCardiac' I/R' and' the'Effect' of'Genetic'CX3CR1'
Knockout'
!






consecutive!bleeds!at! baseline,! 2h!and!24h!post>cardiac! I/R! to!permit! comparison!
between! time!points!within!any!one! individual.!Circulating!monocyte!subpopulation!






subpopulation! count! between! genotypes,! classical! and! intermediate! monocytes!
showed!no!significant!difference!in!the!severity!of!cell!depletion!between!Cx3cr1+/+,!




















Absolute! Trucount! of! peripheral! circulating! classical! [CD11b+CD115+LY6G>LY6Chi!
CCR2hiCX3CR1mid>hi],! intermediate! [CD11b+CD115+LY6G>LY6Cinter!
CCR2midCX3CR1mid>hi],! and! non>classical! [CD11b+CD115+LY6G>LY6CloCCR2lo!
CX3CR1hi]! monocytes! at! baseline,! 2h,! and! 24h! post! cardiac! I/R,! in! Cx3cr1+/+,!
Cx3cr1+/GFP,!and!Cx3cr1GFP/GFP!mice.!Black!triangle!points!=!C57BL/6.!Orange!points!
=! baseline!mice! without! repeated! bleeds.! Data! refers! to!mean! ±! SEM.! Data! was!
analysed!by!Repeated!Measures!One>way!Anova!with!Tukey’s!multiple!comparison!
test.! *p<0.05.! n=2! C57BL6,! n=2! Cx3cr1+/+,! n=4! Cx3cr1+/GFP! (repeat! bleeds),! n=5!

































































































































































































































































circulation! at! 2h! following! cardiac! I/R,! and! the! stronger! depletion! of! non>classical!
monocytes! in! the!Cx3cr1GFP/GFP!circulation.!This!was! investigated!by!examining! the!
adherence!of!monocytes!to!the!coronary!endothelium!and!infiltration!of!monocytes!into!










included! as! control! groups! to! quantify! myocardial! leukocytes! in! steady! state! and!
following!thoracotomy!surgery!without!ischemia!reperfusion,!respectively.!The!remote,!
uninjured! myocardium! (RV)! served! as! an! internal! control! for! these! experiments!
(Figure!5.6B).!Control>stained!heart!tissue!with!no!antibody!and!no!primary!antibody!
were! clean! showing! specificity! of! the! immunostaining! (Figure! 5.5B).!
!
The!temporal!leukocyte!response!was!firstly!evaluated!in!wild!type!mice!(Figure!5.6A).!












To! investigate! the! importance!of!CX3CR1!expression! in! this! leukocyte!response!to!
cardiac!I/R,!the!same!analysis!was!performed!on!Cx3cr1+/GFP!and!Cx3cr1GFP/GFP!hearts!
and! compared!with!wild! type! (Cx3cr1+/+! littermates!and!C57BL/6)!mice.! Leukocyte!










infiltration! increased! from! 2h! by! 5.6>fold,! 10.6>fold! and! 10.7>fold! in! Cx3cr1+/+,!
Cx3cr1+/GFP,! and! Cx3cr1GFP/GFP! mice,! respectively! (Figure! 5.6.E).! This! leukocyte!
response!at!24h!post>I/R!was!specific!to!cardiac!I/R!in!all!genotypes!since!leukocyte!
infiltration! was! consistently! significantly! higher! in! 24h! I/R! hearts! compared! to! 24h!
sham! hearts! (p<0.0001)! and! compared! to! naïve! hearts! (Figure! 5.6B,! p<0.0001).!
Unlike!at!2h!post>I/R,!total!leukocyte!counts!at!24h!I/R!were!not!significantly!different!


























































































































































































































































n=5).! One@way! Anova! with! Tukey’s! multiple! comparison! test.! B.! Comparison! of!
leukocyte!infiltration!between!injured!(LV)!and!remote!(RV)!heart!regions!in!Cx3cr1+/+!
mice!at!2h!and!24h!post@I/R.!C.!!Baseline!resident!leukocytes!in!Cx3cr1+/+,!Cx3cr1+/GFP,!

















disturb! the! leukocyte! response! to! myocardial! repair! following! cardiac! I/R,! since!






reported! associations! between! the!CX3CR1/CX3CL1!axis! and!myocardial! function!
following!cardiac!I/R!in!both!mouse!models!of!myocardial!I/R!and!STEMI!patients![203,!
209,!210,!288@291].! In! this! study,! it!was! therefore!hypothesised! that!Cx3cr1GFP/GFP!
mice!have!an!impaired!non@classical!monocyte!response!following!cardiac!I/R,!leading!
to!disturbed!myocardial!repair!and!impaired!long@term!cardiac!function.!To!investigate!








classical!monocytes!(Figure!5.22).!Ly6C!was!also! tested!on! the!basis! that! it!would!
















investigate! the! time! course! of! monocyte! subpopulation! infiltration! into! the! injured!
myocardium!in!the!control!group.!At!2h!following!I/R,!Cx3cr1+/GFP!classical!monocyte!





significantly! increase!at!2h!post@I/R.!From!2h! to!24h!post@I/R,! the!Cx3cr1+/GFP!non@
classical!monocyte!population!in!the!injured!myocardium!increased!by!~4@fold,!and!by!
a! further! ~2@fold! at! day! 3! post@I/R! (p<0.01).! When! considering! the! neutrophil!
population,! infiltration!of! these!cells!was!very! low!at!2h! I/R!and!similar! to!2h!sham!
hearts.!By!24h!however,!neutrophil!counts! increased!dramatically!by!~6@fold! in! the!
injured!myocardium! (p<0.0001),! which! was! subsequently! followed! by! a! significant!




The! effect! of! complete! genetic! CX3CR1! ablation! on! these! temporal! dynamics! of!
monocyte!subpopulation!infiltration!into!the!injured!myocardium!at!2h,!24h,!and!3!day!
post@cardiac! I/R! was! assessed! by! comparing! the! Cx3cr1+/GFP! control! group! with!
Cx3cr1GFP/GFP!hearts.! At! all! time! points! studied,! classical!monocyte! infiltration!was!
similar!between!Cx3cr1+/GFP!and!Cx3cr1GFP/GFP!hearts!(Figure!5.13C).!However,!non@
classical! monocyte! counts! in! Cx3cr1GFP/GFP! infarcts! were! ~2@fold! lower! than! in!
Cx3cr1+/GFP!hearts!at!24h!(p<0.05),!although!this!difference!was!not!seen!at!2h.!At!day!
3,! non@classical! monocyte! infiltration! in!Cx3cr1GFP/GFP!mice! showed! a! recovery! in!
response,! reaching! that! seen! in!Cx3cr1+/GFP!hearts.!Quantification!of!neutrophils! in!













































in!Cx3cr1GFP/GFP!hearts.! Identification! of! non@specific! CX3CR1! staining! in!Cx3cr1@/@!
hearts! meant! that! this! antibody! could! not! be! used! in! this! study.! Therefore,! GFP!




















Representative! image! illustrating! the! lack! of! GFP! expression! by! Ly6G+! (green)!






















































































































A.! Representative! images! taken! at! 40x! magnification! of! CD11b! and! GFP!
immunofluorescent!stained!Cx3cr1+/GFP!mouse!heart!tissue,!comparing!sham,!2h!I/R,!
24h! I/R! and! day! 3! I/R! heart! tissue.! CD11b+GFPhi! non@classical! monocytes! (white!
arrow),! CD11b+GFPmid! classical! monocytes! (yellow! arrow),! and! CD11b+GFP@!
neutrophils!(pink!arrow).!B.!Representative!remote!region!field!of!view!(FOV)!images!
at! 40x!magnification! of! CD11b! and!GFP! immunofluorescent! staining! of! day! 3! I/R!
Cx3cr1+/GFP!mouse!heart!tissue.!CD11b+GFPhi!non@classical!monocytes!(white!arrow),!


























I/R.! Data! analysed! by! One@way! Anova! with! Tukey’s! multiple! comparison! test.! B.!
Comparison!of!baseline!myeloid!cell!populations!in!the!LV!in!Cx3cr1+/+,!Cx3cr1+/GFP,!
and! Cx3cr1GFP/GFP! naïve! hearts,! n=3! mice/genotype.! Data! analysed! by! Two@way!
Anova!with!Sidak’s!multiple!comparison!test.!C.!Classical!Monocyte,!D.!Non@Classical!
Monocyte,!and!E.!Neutrophil!infiltration!into!the!LV!at!2h,!24h,!and!day!3!post@cardiac!
I/R! in' Cx3cr1+/GFP! and! Cx3cr1GFP/GFP! mice.! n=4! 2h! I/R' Cx3cr1+/GFP,! n=5! 2h! I/R!
Cx3cr1GFP/GFP.!n=4/genotype!at!24h!I/R.!n=5/genotype!at!day!3!I/R.!Two@way!Anova!






















































































































































































The! previous! section! describes! the! time! course! of! classical! and! non@classical!
monocyte! infiltration! into! the! injured! myocardium! at! 2h,! 24h,! and! day! 3! following!
cardiac!I/R,!in!Cx3cr1+/GFP!and!Cx3cr1GFP/GFP!mice.!Methodological!limitations!however!
meant!that!discriminating!classical!and!non@classical!monocyte!subpopulations!using!
this! technique! proved! challenging.! The! definition! of! each! monocyte! subset! by!
microscopy! relied! on! a! subjective! threshold! of! GFP! and! CCR2! expression.! This!
technique!was!further!limited!by!the!poor!quality!of!CCR2!staining!potentially!leading!
to!an!under@estimate!of!classical!monocyte!numbers.!Due!to!such!uncertainties!with!
the! discrimination! of! classical! and! non@classical! monocyte! subsets,! monocyte!
infiltration!was!re@quantified!as!a!total!monocyte!population!in!the!same!2h,!24h,!and!






post@I/R! however,! the! total! monocyte! infiltrate! in! the! injured! myocardium! in! both!
Cx3cr1+/GFP!and!Cx3cr1GFP/GFP!mice!increased!significantly!from!2h!to!day!3!post@I/R!
(p<0.0001),!by!14.8@fold!and!22.4@fold,!respectively.!This!was!an!increase!from!24h!
by! 4.3@fold! in! Cx3cr1+/GFP! hearts! (p<0.0001)! and! 6.4@fold! in! Cx3cr1GFP/GFP! hearts!
(p<0.0001).! As! such,! both! genotypes! showed! a! similar! pattern! of! total! monocyte!

















































































adhesion! of! monocytes! to! the! endothelium.! As! such,! monocyte! adhesion! to! the!
myocardial! vascular! endothelium!was! quantified! at! 2h! and! 24h! post@I/R.! This!was!
performed! on! the! same! hearts! as! the! monocyte! infiltration! analysis.! Leukocyte!
adhesion!occurs!on!venous!endothelium!prior!to!extravasation,!therefore!veins!were!
imaged!for!monocyte!adhesion!quantification.!Each!heart!had!between!1!and!5!major!
veins! in! the! infarcted! region! and! were! identified! on! the! basis! of! their! known!




occurs,! it!was!a!key! region!of! interest! to! study!monocyte!adhesion! in! response! to!
cardiac! I/R.!Smaller! veins! have! the! potential! to! represent! a! tear! in! the! tissue! and!
therefore!were!excluded!where!confirmatory!endothelial!staining!was!not!available,!in!









adhered! total! monocytes! were! significantly! greater! in! the! injured! myocardium!
compared! to! the! remote! area! (p<0.01),! however! this! difference! was! not! seen! in!
Cx3cr1GFP/GFP!mice!(Figure!5.16A).!When!comparing!2h!post@I/R!monocyte!adhesion!









5.16C).!Counts!of!adhered!classical!monocytes! in! the! infarct! region! in!Cx3cr1+/GFP!




and! non@classical! monocytes! at! 24h! between! genotypes! showed! no! significant!
difference!(Figure!5.16B).!
!











































Myocardial! veins!were! identified! on! the! basis! of! their! known! architecture! and! subFepicardial! position,!which! is! distinct! from! the!
intramyocardial! position! of! arteries.! Monocytes! were! identified! as! total! CD11b+GFP+! cells! and! subdivided! into! classical!








































































































































































































































































Total! monocyte! (CD11b+GFP+),! classical! monocyte! (CD11b+GFPmid)! and! non=
classical!monocyte! (CD11b+GFPhi)! adhesion! to!myocardial! vein! endothelium!at! 2h!


























throughout! the! injured!myocardium.! As! such,! the! infarct! BZ! and! CZ! could! not! be!
accurately! identified! and! defined! in!Cx3cr1+/GFP! hearts,! therefore! GFP+! cells! were!
quantified!within!the!total!infarct!region.!Counts!of!GFP+!cells!within!the!total!infarct!








































































Total Infarct Zone Infarct BZ Infarct CZ










Following! the! recruitment! of! monocyte! subpopulations! into! the! injured! myocardial!
tissue! following! cardiac! I/R,! monocyte! subpopulations! perform! their! own! distinct!
functions! contributing! to! infarct! repair.! Upon! infiltration,! proJinflammatory! classical!
monocytes!release!inflammatory!cytokines!such!as!TNFJα!and!produce!nitric!oxide!to!
mediate! removal!of!necrotic! tissue.!This!proJinflammatory! response!shifts!over! the!
ensuing! days! to! predominantly! a! reparative! phenotype,!mediated! by! nonJclassical!
monocytes!which!release!antiJinflammatory!mediators,!promote!angiogenesis!and!the!
deposition!of!scar!tissue.!In!addition!to!their!own!direct!functions!in!the!innate!immune!
response! to! cardiac! I/R,!monocyte!subpopulations!also!undergo!differentiation! into!
distinct!macrophage!populations!which!perform!their!own!secondary!distinct!functions!
[324].! A! resident! cardiac! macrophage! population! also! exists! in! the! myocardium,!
however!murine!models!of!cardiac!I/R!show!a!complete!loss!of!this!population!within!
the!infarct!at!24h!postJMI![325].!As!such,!macrophage!cells!present!in!the!infarct!from!
24h! postJI/R! are! likely! to! be! derived! from! infiltrated! monocyte! subpopulations.!
Macrophages!exist!as!a!heterogeneous!population,!but!can!be!classified!broadly!as!
either!M1!or!M2!macrophages![326]d!M1!‘inflammatory’!macrophages!are!proposed!to!
arise!predominantly! from!Ly6Chi! classical!monocytes,!and!are!present! in! the!heart!
tissue!at!day!1J3!following!I/R!to!drive!acute!inflammation!and!facilitate!the!clearance!
of!necrotic!material.!At!day!5J7,!it!is!believed!that!M1!macrophages!adopt!a!reparative!




The! importance! of! nonJclassical! monocyte! CX3CR1! expression! in! this! process! of!










In! the!next!part!of! this!work,! I! therefore! investigated! the!effect!of!genetic!CX3CR1!







and!monocyte! populations.!GFP! expression!was! used! to! define! F4/80+!GFPhi!M2!




CD11b+GFPmid! classical! monocytes! in! section! 5.2.4.! Macrophage! subpopulation!
quantification!was!however!interpreted!with!caution!as!for!monocyte!subpopulations!
due!to!some!uncertainty!defining!GFPmid!and!GFPhi!cells!as!discussed!in!section!5.2.5.!
A!representative!40x! image!of!F4/80+GFP+!staining! in! the! infarcted! tissue!at!day!3!
postJcardiac!I/R!is!shown!in!Figure!5.19.!!
!
When! considering! macrophages! as! a! total! population,! Cx3cr1GFP/GFP! mice! had! a!
significantly!lower!count!of!F4/80+!cells!present!in!the!infarct!tissue!compared!to!that!
of!Cx3cr1+/GFP!mice,!by!approximately!1.4Jfold!(p<0.05)!(Figure!5.20).!As!all!F4/80+!
staining! was! found! to! coJlocalize! with! positive! GFP! staining,! this! reduced! infarct!













higher! than! M2! F4/80+GFPhi! macrophages! (p<0.01).! In! Cx3cr1GFP/GFP! mice,! the!
difference!between!macrophage!subpopulation!counts!was!not!significantly!different,!
though!there!was!a!trend!towards!increased!F4/80+GFPmid!M1!macrophages.!Between!
genotypes,! counts! of! day! 3! postJI/R! M1! F4/80+GFPmid! macrophages! were! not!
significantly! different,! however! there! was! a! trend! towards! decreased! numbers! in!
Cx3cr1GFP/GFP! hearts.! The! counts! of! M2! F4/80+! GFPhi! macrophages! in! the! infarct!
region!were!not!different!between!genotypes.!!!
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Total F4/80+ F4/80+GFPhi F4/80+GFPlo












The! study! of! mouse! monocyte! subpopulations! in! the! infarct! heart! by!
immunofluorescence! microscopy! is! limited! by! both! the! number! and! availability! of!
monocyte!subset!marker!detection!antibodies.!Standard!fluorescence!microscopy!is!
restricted!to!the!use!of!four!fluorescent!markers,!including!the!nuclear!marker!DAPI,!
which! for! identifying!a!complex!population! like!nonJclassical!monocytes!presents!a!
challenge.! Other! techniques! such! as! advanced! confocal! allows! the! use! of! an!










To! overcome! the! limitations! imposed! by! immunofluorescent! microscopy! and! to!
achieve!a!more!accurate!level!of!cell!characterization,!an!alternative!method!of!cardiac!
digestion!and!FACS!analysis!was!used!to!study!monocyte!subset!infiltration!into!the!
injured!myocardium!at! 24h!postJcardiac! I/R.!This! time!point!was! chosen! to! further!
investigate! the! reduced!nonJclassical!monocyte! infiltrate! in! the! injured!myocardium!
observed! in! Cx3cr1+/GFP! hearts! compared! to! Cx3cr1GFP/GFP! mice! described! as! in!
section! 5.2.4.! This! cardiac! digest! technique! compromises! a! combination! of!
mechanical! and! enzymatic! digestion! of! the! myocardium! which! generates! a!
suspension!of!isolated!single!viable!cells!that!can!be!analysed!by!flow!cytometry!for!
the! identification,! phenotyping,! and! quantification! of! leukocytes! (details! in! 3.9.3).!
FACS!allowed!me!to!use!a!more!comprehensive!panel!of!markers!than!microscopyd!
CD45,!CD11b,!Ly6C,!Ly6G,!CCR2,!CX3CR1,!GFP,!and!F4/80!(Figure!5.21).!These!






classical! and!Ly6Clo! nonJclassical!monocytes,!while!F4/80!allowed! identification!of!
macrophages.! Expression! of! CCR2! and! GFP! by! each! monocyte! subpopulation!
confirmed!their!identity.!The!relative!expression!of!GFP!by!classical!and!nonJclassical!
monocytes! resembled! that! of!monocyte! subpopulations! in!mouse! blood! and! heart!
tissue!analysed!by!microscopy! (Figure!5.22).!The!LV!and!RV!were!processed!and!










































































GFP!expression!as!heavily! and!microscopy,! as! these!methods!allowed! the!use!of!
Ly6C! expression! to! confidently! define! Ly6Chi! classical! and! Ly6Clo! nonEclassical!
monocytes.!The!GFP!MFI!of!Ly6Chi!nonEclassical!monocytes!in!both!cardiac!digest!
FACS!and!blood!FACS!was!significantly!greater!than!Ly6Clo!classical!monocytes!in!
this! FACS! analysis,! though! this! difference! was! marginal! on! the! FACS! plots.! Zen!
software!was!used!to!analyse!the!GFP!MFI!of!randomly!selected!monocyte!cells!in!













5.2.11!Cardiac!Digest!Analysis! of! Infiltrated!Monocyte!Subpopulations! in! the!
Injured!Myocardium!at!24h!Post?Cardiac!I/R!
!
Following! cardiac! digest,! total! monocyte! and! monocyte! subpopulations! were!
quantified!at!24h!postEI/R!in!the!infarct!region!(LV)!and!remote!myocardium!(RV)!by!
FACS!analysis.!Total!monocytes!were!defined!as!CD45+CD11b+Ly6GE!cells,!which!
were! then! subEclassified! into! classical! LY6ChiCCR2hiCX3CR1/GFPmid,! and! nonE
classical!LY6CloCCR2loCX3CR1/GFPhi!monocytes.!Neutrophil!infiltration!at!24h!postE
cardiac! I/R! was! quantified! as! an! internal! biological! control! as! performed! in!
immunofluorescence!microscopy.!As!monocyte! subset! definition! using! this! cardiac!
digest!technique!did!not!rely!on!GFP!expression,!Cx3cr1+/+!mice!could!also!be!studied.!
To!investigate!the!importance!of!monocyte!CX3CR1!expression!on!the!infiltration!of!
these! cells! into! the! injured! myocardium! at! 24h! postEI/R,! heart! digest! monocyte!














Neutrophil! infiltration! into! the! injured!myocardium!(LV)!at!24h!postEcardiac! I/R!as!a!
proportion!of!total!leukocytes!was!78%,!82%,!and!65%!in!Cx3cr1+/+,!Cx3cr1+/GFP,!and!
Cx3cr1GFP/GFP!mice,!respectively,!and!therefore!dominated!the!immune!response!at!
this! time! point! as! expected! (Figure! 5.23C).! This! proportion! of! neutrophils!was! not!













hearts.! Ly6Clo! nonEclassical! monocytes! compromised! approximately! 2%! of! total!
leukocytes!in!Cx3cr1+/+!mice,!5%!in!Cx3cr1+/GFP,!and!4%!in!Cx3cr1GFP/GFP!mice.!This!
proportion!of!classical!and!nonEclassical!monocytes!of!total!leukocytes!in!the!24h!I/R!
infarct! across! genotypes! was! not! significantly! different! for! either! monocyte!
subpopulation.! As! monocytes! and! macrophages! are! known! to! share! cell! surface!
markers!it!can!be!difficult!to!distinguish!between!these!two!cell!populations,!however!
a!further!analysis!of!monocyte!F4/80!expression!at!day!3!I/R!showed!that!the!majority!




Neutrophil! and!monocyte! populations! were! also! analysed! as! a! proportion! of! total!
myeloid! cells! (Figure! 5.23D).! At! 24h! postEI/R,! the! infarct! myeloid! population! was!
comprised! of! 78.5%,! 81.7%! and! 79.8%! neutrophils! in!Cx3cr1+/+,!Cx3cr1+/GFP,! and!
Cx3cr1GFP/GFP! hearts.! Neutrophil! infiltration! at! 24h! postEI/R! therefore! was! not!
significantly! different! across! genotypes.! Classical! monocytes! occupied! a! similar!




cells! in!Cx3cr1+/+,!Cx3cr1+/GFP,! and' Cx3cr1GFP/GFP!mice,! respectively.! Infiltration! of!
classical!and!nonEclassical!monocytes!at!24h!postEI/R!was!not!significantly!affected!







were! CX3CR1+,! compared! to! 27.91%! in! Cx3cr1+/GFP! mice! (Figure! 5.23F).! In!
Cx3cr1+/GFP! mice,! 27.4%! of! leukocytes! expressed! GFP,! compared! to! 28%! in!
Cx3cr1GFP/GFP!hearts!(Figure!5.23G).!This!analysis!of!CX3CR1/GFP+!expression!in!all!
genotypes!at!24h!postEI/R!suggested!the!presence!of!other!CX3CR1/GFP+!cells!in!the!
infarct! in!addition! to! these!monocytes!subpopulationsb! total!monocytes!represented!
15%!of!total!leukocytes!in!wildEtype!mice,!which!all!expressed!CX3CR1,!however!the!
percentage! of! CX3CR1Eexpressing! leukocytes! was! 25.3%.! Similarly,! Cx3cr1+/GFP!
hearts! had! 17%! total!monocytes! and! 27.9%!CX3CR1+! cells! of! the! total! leukocyte!
population,!and!Cx3cr1GFP/GFP!hearts!showed!19%!monocytes!and!28%!GFP+!cells!of!
total!leukocytes.!The!presence!of!other!CX3CR1/GFP+!cells!in!the!injure!myocardium!




































































































































































































































































































































































subEclassified! as! classical! [LY6ChiCCR2hiCX3CR1/GFPmid]! and! nonEclassical!
[LY6CloCCR2loCX3CR1/GFPhi]!monocytes.!A.!Leukocytes,!total!monocytes,!classical!
and!nonEclassical!monocyte!populations,!and!neutrophils!in!the!24h!postEcardiac!I/R!



































infiltration! into! the! injured! myocardium! at! 24h! I/R! between! cardiac! digest! and!




A! fundamental! comparison! that!was! firstly!made!between! these! two!analyses!was!
leukocyte!infiltration!at!24h!postEI/R!into!the!injured!myocardium!(LV)!compared!to!the!
remote!area!(RV).!Since!the!LV!region!is!the!area!of!tissue!that!is!injured!following!
cardiac!I/R,! the!majority!of!CD45+! infiltrate!was!present! in! the!LV!area!across!both!
techniques.! In!both!cardiac!digest!and!microscopy!analysis!of! leukocyte! infiltration,!




5.24A,! B).! This! agreement! between! analyses! provides! confidence! in! CD45+!
quantification!by!each!technique.!!
!
Analysis!of!myeloid!populations! in! the!Cx3cr1+/GFP!control!group!across! techniques!
showed!that!total!monocyte!and!neutrophil!infiltration!into!the!injured!myocardium!(LV)!
at!24h!postEcardiac!I/R!was!also!not!significantly!different!between!the!two!approaches!
(expressed! as! a!%! of! total! CD11b+!myeloid! cells)! (Figure! 5.24C,! 5.25A).! The! LV!

















proportion! of! total!myeloid! cells.! In!Cx3cr1+/GFP!microscopy! analysed! hearts,!GFP+!
cells! represented! 33%! of! all! CD11b+! cells,! which!was! the! same! as! the! 33%! total!
monocyte! proportion! of!myeloid! cells.! This! proportion! of! infarct!GFP+! cells! in! both!






cardiac! digest! and! FACS,! classical! monocytes! dominated! the! total! monocyte!
population.! The! ratio! of! classical! to! nonEclassical! monocytes! was! approximately!
74%:26%!in!Cx3cr1+/GFP!hearts!and!85%:15%!in!Cx3cr1GFP/GFP!hearts!(Figure!5.25!A,!
B).! In! contrast,! the! proportion! of! classical! monocytes! was! lower! when! cells! were!
analysed! using! immunofluorescence!microscopy! and! the! ratio! of! classical! to! nonE





















cardiac! digest! techniques,! expressed! as! a! proportion! of! total! myeloid! cells.! D.!
Percentage! GFP+! cells! of! total! CD11b+! cells! in! cardiac! digest! and!
immunofluorescence!staining.!Cardiac!Digest:!n=3!Cx3cr1+/+,!n=2!Cx3cr1+/GFP,!n=5!



































































































































5.2.13& Analysis& of& Spleen& and& Bone& Marrow& Monocyte& Subpopulations& at&
Baseline&and&24h&Post?Cardiac&I/R& &
!
The!monocyte! immune! response! to! cardiac! I/R! does! not! solely! involve!monocyte!
infiltration!from!the!circulation!into!the!heart!tissue,!but!comprises!a!complex!interplay!










of! single! viable! cells,! and! analysed! by! flow! cytometry! for! monocyte! subset!
quantification.! This! was! compared! with! baseline! mouse! spleen! and! bone!marrow!
monocyte!populations.!The!effect!of!genetic!CX3CR1!ablation!on!splenic!and!bone!
marrow!monocyte! subpopulations! at! baseline! and! 24h! postFI/R! was! evaluated! by!
comparing!Cx3cr1+/GFP!and!Cx3cr1GFP/GFP!mice.!!
!
5.2.14& Splenic& Classical& and& Non?Classical& Monocyte& Subpopulations& at& 24h&
Post?Cardiac&I/R& &
!












significantly! different! between! genotypes! (Figure! 5.27A).! This! proportion! of! total!
monocytes!was!in!the!expected!baseline!range!of!<5%!of!all!splenocytes![345].!When!
comparing!the!total!splenic!monocyte!population!at!baseline!between!Cx3cr1+/GFP!and!




Classical!monocyte! subpopulations! in! spleens! of!Cx3cr1+/GFP!mice! at! 24h! postFI/R!
were!similar!to!baseline!levels,!whether!expressed!as!a!proportion!of!total!splenocytes!
(Figure!5.27C),!myeloid!cells! (Figure!5.27D),!or! total!monocytes! (Figure!5.27E).! In!
contrast!to!this,!Cx3cr1GFP/GFP!mice!suggested!there!was!an!increase!in!the!proportion!






The!difference! in! the! frequency!of!monocyte!subpopulations!between!baseline!and!
24h! I/R! in!Cx3cr1GFP/GFP!mice! are! suggestive! of! two! possible! scenarios! following!
cardiac! I/Rb! i)! genetic!CX3CR1!knockout! leads! to! increased!efflux!of! nonFclassical!

































































































































































































































































































































































































































































































































































cells,! or! total! monocytes.! Data! analysed! by! TwoFway!Anova! with!Tukey’s!multiple!










were! defined! by! flow! cytometric! analysis! as! CD45+CD11b+! cells! (Figure! 5.28).!
Neutrophils!were!excluded!on!the!basis!of!high!SSC!and!intermediate!expression!of!




marrow! leukocytes! and! ~20%! of! all! bone! marrow! myeloid! cells,! which! did! not!
significantly!differ!at!24h!I/R,!or!in!Cx3cr1GFP/GFP!mice!(Figure!5.29A,!B).!Analysis!of!


























distinguished! from! monocytes! as! SSChi! and! Ly6Cinter.! Monocytes! were! then! subF




































































































































































































































































































































































































































































































































































































Bone!marrow! total!monocytes! (A,!B),! classical!monocytes! (CFE)! and!nonFclassical!
monocytes! (FFH)! were! quantified! and! expressed! either! a! percentage! of! total!
splenocytes,!myeloid!cells,!or!total!monocytes.!Data!analysed!by!TwoFway!Anova!with!

















Analysis! of! cardiac! function! parameters! at! 6! weeks! following! myocardial! I/R! in!




deficient!miceb!ESV! increased! incrementally! from!Cx3cr1+/+!(30.1µl),! to!Cx3cr1+/GFP!




was! also! a! trend! towards! decreased! myocardial! function! as! determined! by! lower!








trend! however! suggests! that! a! higher! number! of! animals! per! group!may! increase!
















































































































































































of!CX3CR1,!which!was! confirmed! in! this! study! (section! 5.2.1).! Immunofluorescent!
microscopy!definition!of!classical![CD11b+!GFPmid]!and!nonFclassical![CD11b+!GFPhi]!
monocyte!subsets! relied!on!a!subjective! threshold!of!GFP!expression/intensity.!As!
previously! discussed,! there! is! potential! for! quantitative! overlap! between!monocyte!
subsets! due! to! this! subjective!method! of! quantification.&FACS! analysis! of! cardiac!
digest!monocyte!populations!allowed!a!more!comprehensive!panel!of!markers!for!the!
detection!of!monocyte!subsets!and!therefore!more!accurately!distinguished!classical!










previously! described! with! the! additional! marker! of! PDFL1! incorporated! into! the!
antibody! panelb! classical! monocytes! [CD11b+CD115+LY6GFLY6ChiCCR2hi!
CX3CR1midFhi],! and! nonFclassical! monocytes! [CD11b+CD115+LY6GFLY6ChiCCR2mid!
CX3CR1hi].! In! the! peripheral! blood,! mouse! circulating! nonFclassical! monocytes!




(p<0.0001)! (Figure! 5.31A).! Importantly,! PDFL1! expression! was! found! to! be! more!
accurate! at! quantifying! the! nonFclassical! monocyte! population! than! CX3CR1!
expression,!when!analysed!as!a!proportion!of!total!leukocytes!(Figure!5.31D),!or!total!
CD115+! cells! (Figure! 5.31E).! Titration! of! the! PDFL1! antibody! in!mouse! blood!was!




PDFL1! than! circulating! monocytes,! with! no! significant! difference! in! expression!
between!monocyte!subpopulations!(Figure!5.31A).!Monocytes!in!the!bone!marrow!are!
known! to! be! primarily! classical! monocytes! (95F100%),! with! only! 1F5%! of! total!




could! not! be! reliably! measured.! Classical! monocytes! however! were! abundant! in!
number! and! were! found! to! express! high! levels! of! PDFL1,! similar! to! those! levels!
expressed!by!circulating!nonFclassical!monocytes!(Figure!5.31A).!This!is!particularly!
interesting!as!it!may!be!the!case!that!circulating!Ly6Clo!nonFclassical!monocytes!in!the!
blood! express! high! levels! of! PDFL1! as! they! originate! from! bone! marrow! Ly6Chi!
classical!monocytes!which!express!high!levels!of!PDFL1.!!
!
In! humans,! to! my! knowledge! there! are! no! published! studies! investigating! the!
expression!of!PDFL1!by!human!circulating!monocyte!subsets.!This!may!be!due!to!the!
lack! of! requirement! for! an! exclusive! nonFclassical!marker! since!CD14,!CD16,! and!
CX3CR1!adequately! define! the! three!populations!of!monocytes! in! humans.! In! this!
study,! I! therefore! investigated! whether! PDFL1! expression! was! higher! on! human!
circulating! nonFclassical! monocytes! than! classical! monocytes! as! observed! in! the!
mouse.!This!analysis!showed!that!while!CX3CR1!expression!was!significantly!greater!
in! nonFclassical! and! intermediate! monocytes! compared! to! classical! monocytes!













CX3CR1+! and! PDFL1+! leukocytes! compared! with! the! percentage! of! Ly6Clo! nonF
classical! monocytes! (n=5).! E.! Percentage! of! CX3CR1+! and! PDFL1+! CD115+!
monocytes!compared!with!the!percentage!of!Ly6Clo!nonFclassical!Monocytes!(n=5).!
D,! E.! OneFway! Anova! with! Tukey’s! multiple! comparison! test.! F.! Expression! of!
CX3CR1! compared! with! PDFL1! to! distinguish! nonFclassical,! intermediate,! and!
classical!monocyte!populations!in!human!control!blood!(n=3!human!volunteer!blood!





































































































































































Unlike! in!humans,! the!use!of!mouse!models!permits! investigation! into! the!effect!of!
CX3CR1!knockout!on! these!circulating!nonFclassical!monocyte!dynamics,!by!using!
the!Cx3cr1EGFP!mouse!line.!Cx3cr1GFP/GFP!mice!showed!significantly!lower!counts!of!
peripheral! blood!nonFclassical!monocytes! than'Cx3cr1+/+! (*p<0.05)! and!Cx3cr1+/GFP!
mice! (*<0.05),! while! classical! and! intermediate! subpopulations! were! unaffected.!
These!results!are!in!agreement!with!those!published!by!Landsman!et!al![218],!who!
explain! that! the! reduction! in!circulating!nonFclassical!monocytes! is!due! to! impaired!
survival!signals!in!the!absence!of!CX3CR1!expression.!Auffray!et!al!also!showed!that!
deletion!of!CX3CR1!reduces!the!patrolling!of!nonFclassical!monocytes,!which!results!
in! overall! fewer! circulating! counts! of! these! cells! [150].! Furthermore,! Poupel! et! al!
demonstrated! that! pharmacological! inhibition! of!CX3CR1! reduces! blood!monocyte!





blood! showed! that! nonFclassical!monocyte! counts! fell! in! the! circulation! at! 2h,! and!
therefore!mirrored!the!depletion!of!STEMI!patient!nonFclassical!monocytes!at!90min!




reperfusion! depletion! of! mouse! nonFclassical! monocytes! at! 2h! was! found! to! be!




monocyte! subpopulation! dynamics! from! preF2h! postFI/R!may! be! attributed! to! their!
similar!expression!of!CX3CR1b!in!STEMI!patients,!there!was!a!greater!drop!in!cells!
with! increased!CX3CR1!expression,!whereby!nonFclassical!monocytes! (CX3CR1hi)!




compared! to! that! of! Cx3cr1+/+! mice! at! 2h! postFI/R! may! indicate! an! increased!
recruitment!of!these!cells!from!the!peripheral!circulation!to!the!injured!myocardium!in!
CX3CR1Fdeficient!mice.!A!possible!explanation!for!this!is!that!circulating!nonFclassical!
monocytes! in! Cx3cr1+/+! mice! can! firmly! adhere! to! the! vascular! endothelium! via!








At! 24h! postFcardiac! I/R,! all! monocyte! subpopulations! were! replenished! in! the!
circulation,!which!is!likely!to!reflect!the!release!of!these!cells!from!the!spleen!as!known!
to! occur! following! MI! [316,! 349].! This! is! also! supported! by! the! decrease! in! the!
percentage!of!splenic!nonFclassical!monocytes!at!24h!I/R!described!in!section!5.2.11.!









is! not! widely! documented! in! mouse! models! to! date,! as! many! studies! focus! on!




Finally,! it! is! important! to! address! the! validity! of! this! data!with! consideration! to! the!
methodological! limitations! of! the! techniques! used.! For! ethical! reasons,! there! is! a!
limitation!on!the!volume!of!mouse!tail!vein!blood!that!may!be!obtained!for!analysis.!
Within! this! protocol,! blood! samples!were! limited! to! a! small! volume! of! 50µl,! which!
arguably!may!not!be!large!enough!to!yield!a!representative!analysis!of!cell!populations!
in!the!peripheral!blood.!Theoretically!there!should!be!minimal!variation!in!monocyte!









by! immunofluorescent! staining! of! mouse! heart! tissue.! Leukocyte! recruitment!
dramatically! increased! at! 24h! postFI/R! compared! to! control! hearts! (p<0.0001).!
Cx3cr1GFP/GFP!hearts!showed!significantly!reduced!counts!of!leukocytes!compared!to!














then! increased! in! the! injured! myocardium! at! 24h! post! I/R.! Classical! monocyte!
recruitment!was!not!significantly!affected!by!genetic!CX3CR1!knockout,!however!nonF
classical!monocyte!counts!were!significantly! reduced! in!Cx3cr1GFP/GFP!compared! to!
Cx3cr1+/GFP! hearts! (p<0.05).! Analysis! of! monocyte! subpopulation! adhesion! to! the!
myocardial!vein!endothelium!at!2h!postFI/R!showed!that!Cx3cr1GFP/GFP!mice!did!not!
have!reduced!adherence!of!nonFclassical!monocytes!compared!to'Cx3cr1+/GFP!miceb!
the! reduced! nonFclassical! monocyte! population! in! 24h!Cx3cr1GFP/GFP! infarcts! was!
therefore!more!likely!to!be!due!to!a!migration!or!extravasation!defect!than!impaired!
adhesion.! Other! studies! have! reported! a! central! role! of! CX3CR1! in! monocyte!
adhesion,! for! example! Poupel! et! al! have! shown! that! both! in! vitro! and! in! vivo!
pharmacological! inhibition! of! CX3CR1! attenuates! monocyte! adhesion! [348],! while!
recent!phenotypic!studies!with!mouse!models!of!atherosclerosis!have!revealed!that!
CX3CR1! deficiency! significantly! reduces! monocyte! infiltration! into! the! vessel! wall!
[287].!The!similar!levels!of!nonFclassical!monocyte!myocardial!vein!adhesion!observed!
in!this!study!at!2h!could!be!explained!by!the!fact!that!CX3CR1Fexpressing!cells!can!
also! adhere! to! the! endothelium! in! a! mechanism! that! is! independent! of! CX3CR1!
signalling!and!integrin!activation![188,!351].!The!lack!of!difference!may!also!be!due!to!
the!comparison!made!between!Cx3cr1+/GFP!and!Cx3cr1GFP/GFP!mice,!which!does!not!
consider! the!monocyte! adhesion! phenotype! in!CX3CR1+/+!mice.! It! is! possible! that!







nonFclassical! monocyte! counts! dramatically! increased! from! 24h,! which! was! not!
significantly! affected! by! genetic! CX3CR1! knockout.! The! reduced! nonFclassical!
monocyte! response! in! CX3CR1! knockout! hearts! at! 24h! may! therefore! indicate! a!
delayed! response! of! these! cells! rather! than! complete! reduced! infiltration! in! the!









may! influence! the! migratory! behaviour! of! infiltrated! monocytes! in! the! injured!
myocardium!at!day!3!postFI/R.!CX3CR1!is!known!to!mediate!the!migration!of!CX3CR1+!






monocyte! infiltration! into! the! injured! myocardium,! the! results! of! this! monocyte!
subpopulation!analysis!in!the!infarct!between!2h!and!day!3!following!I/R!sheds!light!
on!the!temporal!dynamics!of!these!cells!after!I/R.!The!traditional!paradigm!describes!
that!nonFclassical!monocytes! infiltrate! the! injured!myocardium! from!day!5!postFI/R,!
peaking!at!~day!7,!however!in!this!study!there!appears!to!be!a!distinct!population!of!
infarct! nonFclassical! monocytes! at! 24h! following! reperfusion.! Other! recent! studies!





important! role! of! CX3CR1hi! nonFclassical! monocytes.!
!
It!is!important!to!address!the!validity!of!this!immunofluorescence!monocyte!data!with!
consideration! to! the! methodological! limitations! of! the! technique.! Definition! of!
monocyte!subpopulations!in!the!heart!tissue!by!microscopy!described!in!this!chapter!
relied!on!the!method!of!manual!quantification!of!CD11b+!GFPmid!classical!monocytes!
and!CD11b+GFPhi! nonFclassical!monocytes.! The! distinction! between! classical! and!
nonFclassical!monocytes!relied!more!heavily!on!the!level!of!GFP!expression!due!to!





GFP!MFI! by!CD11b+GFPmid! classical!monocytes! and!CD11b+!GFPhi! nonFclassical!
monocytes! showed! a! significant! difference! in! GFP! expression! between!monocyte!




laser,! which! renders! automated! software! unable! to! distinguish! autoFfluorescent!






method!of!monocyte! subpopulation!quantification! in! the!heart! tissue!was! therefore!
unlikely! to! have! had! a! significant! impact! upon! the! results! reported.! Furthermore,!
monocytes!were!quantified!as!total!population,!which!could!be!confidently!identified!







and! nonFclassical! monocyte! subpopulations! in! the! infarct! at! 24h! postFI/R! did! not!
significantly! differ! between! Cx3cr1+/+,! Cx3cr1+/GFP,! and! Cx3cr1GFP/GFP! hearts.! This!





determined! by! cardiac! digest! flow! cytometry! and! immunofluorescence!microscopy!






[Ly6ChiCCR2hiCX3CR1midFhi]! and! nonFclassical! [Ly6CloCCR2midCX3CR1hi].! ! Such!
differences!in!monocyte!subpopulation!proportions!determined!by!cardiac!digest!flow!
cytometry!and!immunofluorescence!microscopy!may!also!be!due!to!inefficiencies!in!
antigen! detection! in! fixed! tissues.! This! is! likely! for! mouse! heart! tissue! monocyte!





of! the!mechanical! and! enzymatic! digestion! step! affecting! certain! cell! populations.!









assessed!at!day!3! following!cardiac! I/R!as!monocyte!subpopulations!are!known! to!
differentiate! into! their! respective!macrophage! populations! following! their! infiltration!





populations! in! the! infarct! at! day! 3! postFI/R,! though! there! was! a! noticeable! trend!
towards! lower! counts! of! M1! macrophages! in! Cx3cr1GFP/GFP! hearts.! When!






differentiation! of! classical! monocytes! into! M1! macrophages! following! cardiac! I/R.!
Other! reports! have! demonstrated! that! CX3CR1! plays! an! important! role! in! the!
phenotypic!conversion!and!proFinflammatory!functional!polarization!of!monocytes!in!
the! liverb! macrophages! in! Cx3cr1+/GFP! mice! have! a! stronger! proFinflammatory!
phenotype! than! in!Cx3cr1GFP/GFP! mice! [356].! The! observed! reduced! population! of!
macrophages! in! Cx3cr1GFP/GFP! infarcts! (Figure! 5.20)! may! also! be! a! result! of! the!




of! macrophage! subpopulations! used! in! this! study! by! microscopy! may! be! an!
oversimplification!of!this!heterogeneous!cell!typeb!currently!the!M1/M2!classification!of!
macrophages! is! criticized! for! not! fully! covering! the! total! spectrum! of! macrophage!
phenotypes.! Particularly! in! a! pathological! context,!macrophages! demonstrate! high!
plasticity,! modifying! their! expression! and! transcription! profile! along! a! continuous!
spectrum,!with!M1!and!M2!phenotypes!as!the!polar!extremes![358,!359].!With!this!in!
mind! it! is! possible! that! there! is! quantitative! overlap! in! the! counts! of! M1! and! M2!
macrophages!at!day!3!post! I/R!described! in! this! study.! In!addition! to! this,! surface!










this! was! not! statistically! significant.! Such! findings! indicate! that! complete! genetic!
knockout!of!CX3CR1!may! lead! to! the! release!of!nonFclassical!monocytes! from! the!
spleen! and! their! egress! from! the! bone!marrow! at! 24h! following! cardiac! I/R.! This!
process!would!explain! the! increase! in!mouse!nonFclassical!monocytes!observed!at!






possible! that! there! is! an! increase! in! classical! monocytes! in! the! spleen! and! bone!
marrow,! rather! than! a! decrease! in! their! nonFclassical! counterpart.! However,! the!





This! study! confirmed! a! previous! report! showing! that! PDFL1! is! a! useful!marker! for!
defining! nonFclassical! monocytes! from! classical! monocytes! in! mouse! blood! [360].!
Further!research!is!required!to!determine!if!this!significantly!greater!expression!of!PDF
L1!by!nonFclassical!monocytes!compared!to!classical!monocytes!is!also!seen!in!the!
heart! tissue!monocyte!populations!postFcardiac! I/R.!Such!a! tool!may! facilitate!nonF





















Based! on! these! studies,! it! could! be! suggested! that! Cx3cr1GFP/GFP! mice! may! be!
protected!from!cardiac!injury!and!demonstrate!improved!cardiac!function!following!I/R,!
compared! to! control! mice.! As! such,! the! effect! of! genetic! CX3CR1! knockout! on!
myocardial! function!following!I/R!was!examined!at!6!weeks!following!reperfusion!in!
this! study.! This! analysis! revealed! that! there! was! no! significant! effect! of! genetic!
CX3CR1! ablation! on!mouse! ejection! fraction! at! 6!weeks! following! I/R.! There!was!
however!a!notable!trend!towards!improved!cardiac!function!with!increased!CX3CR1!
expression,! observed! as! a! small! incremental! decrease! in! ejection! fraction! from!
Cx3cr1+/+,!to!Cx3cr1+/GFP,!to!Cx3cr1GFP/GFP!hearts.!While!this!observation!contradicts!
the!cardioFprotective!role!of!CX3CL1/CX3CR1!neutralization!reported!by!others,!it!may!
be!explained!by! the!method!of! inhibition.!Furthermore,! it! is! possible! that! a! lack!of!
phenotype!observed!in!this!study!is!due!to!the!modest!sample!size!of!the!groups!usedb!











To! study! the! effect! of! CX3CR1! knockout! on! any! biological! function! in! mice,! the!
Cx3cr1GFP/GFP!mouse!is!a!valuable!tool.!In!this!construct,!the!first!320bp!of!the!CX3CR1!






deficiency! on! monocyte! behaviour! from! its! effects! on! the! immune! system! more!




consequence!of!CX3CR1!deficiency!on!other! immune!cell! types.!Furthermore,! it! is!
possible! that!Cx3cr1F/F! ! mice! may! have! developed! compensatory! mechanisms! to!
overcome! the! lack! of!CX3CR1!expression,! in! order! to! function! normally.! It! is! also!
important!to!consider!that!different!mechanisms!of!inhibition!of!the!CX3CL1/CX3CR1!




By! contrast,! findings! in! Cx3cr1GFP/GFP! mice! by! Landsman! et! al! showed! a! 3Ffold!
reduction! in! resident! monocyte! numbers,! with! no! alteration! in! the! number! of!
inflammatory! monocytes! [218].! Targeted! disruption! of! the! mouse! CX3CL1! gene!
however!does!not!appear!to!generate!any!detectable!!phenotypeb!Cx3cl1F/F!mice!have!
no!histologic!abnormalities!in!any!major!organs,!and!hematopoietic!lineages!in!blood!
and! lymphoid! tissue! are! essentially! normal! [226].! Cx3cr1F/F! mice! also! do! not!
demonstrate!differences!to!wildFtype!mice!with!regard!to!monocyte!recruitment,!DC!
differentiation!and!migration,!or!microglial!responses![277].!The!exact!mechanism!of!
CX3CL1/CX3CR1! axis! inhibition! may! therefore! lead! to! alternative! monocytic!
phenotypes!that!affect!outcome!on!cardiac!function!following!I/R.!This!discrepancy!is!
not!unique!and!may!exist! for!several! reasons,!one!of!which! is! the!aforementioned!
compensatory!mechanisms!that!take!place!in!geneFdeleted!mice!during!development.!
There! is! also! potential! for! the! existence! of! other! sites! of! action! of! the! CX3CR1!
antagonist!that!have!not!yet!been!identified.!!!
!





classical! subpopulations! are! broadly! conserved! across! human! and! mice,! the!
monocyte!subpopulations!in!each!species!are!defined!by!different!markers!(Ly6C!in!
mice,!CD14!and!CD16!in!humans),!though!these!markers!are!unlikely!to!govern!their!
function.! Furthermore,! comparison! of! monocyte! gene! expression! profiles! between!




expressed!between!species’! subsets! [361].!For! the! study!of! the!CX3CL1/CX3CR1!
axis,!it!is!also!difficult!to!extrapolate!findings!from!human!monocytes,!where!there!is!
an! obvious! greater! difference! in! CX3CR1! expression! by! nonFclassical! monocytes!
compared! to!classical!monocytes,! to!mice,!where!Ly6Chi!classical!and!Ly6Clo!nonF








This! study! demonstrates! that! mouse! blood! nonFclassical! monocyte! counts! are!
significantly! reduced! in! response! to! genetic! depletion! of! CX3CR1,! and! therefore!
supports!existing!reports!of!the!effect!of!CX3CR1!expression!on!monocyte!survival.!





of! CX3CR1! expression.! These! findings! however! need! to! be! confirmed! by! other!
methods!of!studying!monocyte!infiltration!into!the!myocardium,!such!as!using!PDFL1!
which! is! shown! in! this! study! to! be! a! useful!marker! of! the! nonFclassical!monocyte!






following!cardiac! I/R,! the!signalling!pathways!downstream!of! this! receptor!must!be!
characterised.!Recent!efforts! to!define! these!pathways!have!provided! initial! insight!
into!the!molecular!mechanisms!regulating!nonFclassical!monocyte!function,!but!remain!
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following!cardiac! I/R,! the!signalling!pathways! that!are!activated!downstream!of! this!
receptor! following! CX3CL1! binding! must! be! characterised.! Recent! efforts! have!
demonstrated! that! a! number! of! different! signalling! pathways! may! be! induced!
downstream! of! CX3CR1,! though! this! evidence! is! varied! and! largely! inconclusive.!
Among!those!studied,!the!NF!B!signalling!pathway!has!most!frequently!been!shown!
to!be!a!potential!downstream! target!of!CX3CR1!signalling.!These! reports!however!
cover! a! broad! range! of! immune! cells,! and! the! evidence! of! NF!B! activation! by!
CX3CL1/CX3CR1!specifically!in!monocytes!is!sparse.!Activation!of!NF!B!specifically!
following!myocardial!I/R!has!been!documented!by!a!number!of!studies![362,!363],!and!
importantly! its! inhibition! has! been! shown! to! be! cardioprotective! [364,! 365],! as!
determined! by! reduced! I/R! injury,! attenuated! infarct! size,! and! improved! cardiac!
function! after! MI! [3668369].! The! aim! of! this! chapter! was! therefore! to! investigate!
activation!of!this!pathway!in!human!non8classical!monocytes!in!response!to!CX3CL1!
stimulation,!which!may!help!to!explain!the!function!of!these!cells!following!reperfusion.!
The! NF!B! pathway! regulates! gene! transcription,! cytokine! production,! and! cell!
survival.!Such!functions!downstream!of!NF!B!signalling!could!be!crucial!to!monocyte!
function!following!CX3CL1!stimulation!after!cardiac!I/R.!To!study!the!monocyte!NF!B!
response! to! CX3CL1/CX3CR1! stimulation,! the! human!monocyte! cell! lines! THP81,!




CX3CR1! by! human! monocyte! cell! lines! and! freshly! isolated! human! classical,!











however! focussed! on! the! two! best8understood! phosphorylation! targets! within! the!
NF!B! p65! subunit,! S276! and! S536! [371].! In! the! NF!B! signaling! cascade,!
phosphorylation! of! p65! is! required! for! nuclear! translocation! and! transcriptional!





































intermediate,! or! non8classical! human!monocytes.! To! address! this,! human!PBMCs!
from!volunteer!peripheral!whole!blood!were!isolated!by!Ficoll!separation,!and!analysed!
by! FACS.! In! parallel,! cultured! THP81! cells! were! analysed! for! monocyte! marker!
expression.!!
!
The! results! of! this! analysis! showed! that! human! blood! monocyte! subpopulations!
expressed! their! respective! characteristic! levels! of! monocyte! markersZ! classical!
monocytes! (CD168CD14++CCR2hiCX3CR1lo),! intermediate! monocytes!
(CD16+CD14+CCR2midCX3CR1mid),! and! non8classical! monocytes!
(CD16++CD14loCCR2loCX3CR1hi)! (Figure! 6.2).! Immunophenotyping! of! THP81!
monocytes!revealed!that!these!cells!were!CD168CD14++CCR2mid8hiCX3CR1lo!(Figure!





The! results!of! this! initial!profiling!of! the!THP81!human!monocyte!cell! line! therefore!




























































































































































































































































































































































































































































































































































































as! models! for! investigating! human! monocyte! function,! regulation,! and! signalling!
pathways! in! vitro! [375/377].! These! monocyte! lines! were! immunophenotyped! for!





1.7/fold!greater! than!THP/1! cells! (Figure!6.4A).!The!MM6!cell! line!also!expressed!




























































































CX3CR1 Expression by 








To! date,! the! signalling! pathways! that! are! activated! downstream! of! CX3CR1!
stimulation!by!CX3CL1!are!poorly!understood.! Initial! insights!have!pointed! towards!
activation!of!the!NF!B!pathway![378/381]!by!CX3CL1/CX3CR1!in!a!range!of!cell!types!
including!microglia,! intestinal! epithelial! cells,! and! neurons.! The! evidence! reporting!
CX3CR1/induced!activation!of!NF!B!specifically!in!monocytes!however!is!lacking.!In!
this!chapter,! I! therefore!hypothesised!that!CX3CL1!binding!to! its!receptor!CX3CR1!
induces! NF!B! activation! in! human! monocytes,! which! leads! to! an! increased! pro/
inflammatory! response!of! these! cells.!Through! this! upregulation!of!NF!B!and!pro/
inflammatory! response! in!monocytes,! CX3CL1!may! exert! its! detrimental! effect! on!
myocardial!repair!following!cardiac!I/R.!!
!





phosphorylated! p65! subunit! of! NF!B! translocates! into! the! nucleus! to! regulate! the!
expression!of! inflammatory!mediators!and!MMPs! [382,!383].!Activation!of$NF!B! is!
known!to!be!induced!by!pro/inflammatory!cytokines!such!as!TNF/",!which!results!in!
nuclear! translocation! of! the! p50/p60! heterodimers! [384].! Based! on! this! known!
phenomenon,!TNF/α!stimulation!was!employed!as!a!positive!control!in!this!study.!!
!












at! both! 60min! and! 120min,! which! was! not! notably! different! between! 10,! 50,! and!
100ng/ml!concentrations!of!CX3CL1!at!either!time!point.!Based!on!this!observation,!







was! included! to! examine! prolonged! versus! transient! phosphorylation! of! p65.! At!
10ng/ml,!CX3CL1!did!not!induce!significant!phosphorylation!of!p65!at!either!15,!30,!
60,! or! 180min! (Figure! 6.5B,! D).! Of! all! the! time! points! studied,! THP/1!monocytes!
showed! a! slight! increase! in! phosphorylated! p65! at! 60min! compared! to! that! of!
untreated!cells,!though!this!increase!was!modest!and!not!significant.!TNF/"/treated!
cells! showed! a! significant! increase! in! phosphorylated! p65! (p<0.01).! At! a! higher!





Based! on! these! findings,! stimulation! of! THP/1! monocytes! with! CX3CL1! at! a!
concentration!of!10ng/ml!for!60!minutes!was!repeated!to!identify!whether!the!modest!
NF!B! response! observed! under! these! conditions! was! reproducible! and! therefore!
valid.!Following!repeated!experiments,!this!optimised!dose!and!timing!of!CX3CL1!at!
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after!15min!at!10ng/ml.!A.!Dose! response! to!CX3CL1!at!10,!50,!and!100ng/ml! for!
60min!or!120min.!B.!Time!response!to!CX3CL1!at!10ng/ml!for!15,!30,!60!and!180min.!
C.!Time!response!to!CX3CL1!at!50ng/ml!for!15,!30,!60!and!180min.!One/way!Anova!
with! Tukey’s! multiple! comparison! test.! Data! refers! to! mean! ±! SEM.! **p<0.01.! D.!





























































































inhibitor$ BI605906$ dose$ response$ inhibition$ of$ CX3CL1<induced$ p65$
phosphorylation$
!
Following! the!observation! that!CX3CL1!can! induce!modest!phosphorylation!of!p65!
during!optimal!conditions!(10ng/ml!CX3CL1,!60min),!the!next!aim!of!this!work!was!to!






while!Zhang!et!al! [386]!show! inhibition!of! IKKβ!by!BI605906!at!5μM.! In!addition! to!
IKKβ,! a! number! of! kinases! have! been! identified! that! phosphorylate! p65/Ser536!









was! stored! in!DMSO.!At! the! lowest! concentration!of!BI605906!of! 0.5μM,! levels!of!
phosphorylated!p65!were!not!significantly!different!from!CX3CL1/only!treated!cells.!At!
1μM! BI605906! however,! CX3CL1/induced! p65! phosphorylation! was! significantly!
reduced!(p<0.05).!Treatment!with!higher!concentrations!of!the!IKKβ!inhibitor!BI605906!
at!2.5μM!and!10μM!further!decreased!phosphorylated!levels!of!p65,!to!below!that!of!
CX3CL1/only! treated! cells! (p<0.01).!Notably,! inhibition! of! IKKβ! by!BI605906! at! all!







Secondly,! to!determine! if! the!previously!observed!p65!phosphorylation!was! truly!a!
response!to!CX3CL1!and!not!any!other!confounding!stimuli,!the!CX3CR1!antagonist!








was!used!as!a! control,!which! is! the!buffer! used!by! the!manufacturer! (Kancera)! to!
dissolve!the!inhibitor.!
!
In! contrast! to! incubation!with! the! IKKβ! inhibitor! BI605906,! pre/incubation!with! the!
CX3CR1! inhibitor! KAN567! for! 30! minutes! prior! to! CX3CL1! treatment! did! not!













































































































Inhibition of CX3CL1-induced NFκB activation of 






















































































Inhibition of CX3CL1-induced NFκB activation of 






















is! an! inducible! transcription! factor! which! upon! activation,! targets! inflammation! by!
directly! increasing! the! production! of! pro(inflammatory! cytokines,! chemokines,! and!
adhesion!molecules.!NF!B!also!regulates!cell!proliferation,!apoptosis,!morphogenesis!
and!differentiation! [391].!Among! the!most!well(established! inducers!of!NF!B! in! the!
context!of!inflammation!are!members!of!the!TNF!family!of!cytokines![392,!393].!TNF(
"!is!known!to!upregulate!transcription!of!pro(inflammatory!genes!IL(8,!IL(6,!and!IL(1#!







has! however! not! been! explored! to! date.! Based! on! the! previous! observation! that!
CX3CL1! stimulation! can! lead! to! slight! induction! of! p65! phosphorylation! in! THP(1!
monocytes,!the!next!part!of!this!work!was!to!identify!downstream!target!genes!of!NF!B!
signalling!that!are!regulated!by!CX3CL1!stimulation.!Elucidation!of!such!target!genes!




















Data! shown! in! Figure! 6.8A! shows! that! IL(8! expression! was! increased! by! TNF("!
stimulation!for!either!2h!or!6h!at!10ng/ml!compared!to!untreated!cells,!however!this!
was!not!significant.!Stimulation!of!THP(1!cells!with!CX3CL1!for!2h!did!not!significantly!
change! the! expression! levels! of! IL(8! at! either! concentration! of! CX3CL1! tested.! A!
longer!stimulation!of!CX3CL1!at!10ng/ml!for!6h!however!lead!to!a!significant!increase!




























































































































































































































of! p65! phosphorylation! in! response! to! CX3CL1! stimulation! (10ng/ml! 60min).!
Downstream!of!this!activation,!THP(1!monocytes!showed!modest!upregulation!of!IL(






Due! to! their! high! expression! levels! of! CX3CR1,! non(classical! monocytes! would!






Furthermore,! gene! expression! data,! CD!marker! profile! and! functional! chemotaxis!




human! whole! blood/PMBCs.! Techniques! to! isolate!monocytes! from! human! whole!
blood!are!fairly!established,!however!there!is!evidence!that!the!choice!of!monocyte!
enrichment! protocol! significantly! affects! the! yield,! purity,! relative! abundance! of!





Based! on! these! reports,! this! study! used! a! negative! human! monocyte! selection!




conjugated! antibodies! and! subsequent! depletion! of! the! labeled! cells! by! binding! to!
streptavidin(conjugated! magnetic! beads,! while! monocytes! remain! untouched.! The!
Monocyte!Isolation!Kit!II!(Miltenyi!Biotec,!#130(091(153)!contains!anti(CD3!and!anti(
CD7! to! label!T!cells,!anti(CD16!(granulocytes),!anti(CD19!(B!cells),!anti(CD56!(NK!





EDTA! anti(coagulated! blood! was! obtained! from! healthy! volunteers! after! informed!
consent!and! in!accordance!with! the!ethical!guidelines!of! the! institution.!Monocytes!
were! extracted! as! described! in! section! 3.! The! purity! of! human! monocytes! was!







6.9A).! FACS! analysis! of! the! isolated! PBMCs! showed! that! the! total! monocyte!




4.9x!higher! than! that! achieved! from!peripheral!whole!blood!and!22.3x!higher! than!
PMBC! total! monocytes.! The! non(monocyte! fraction! of! PBMCs! was! analysed! to!
confirm!the!effective!extraction!of!monocytes!(Figure!6.9D).!This!population!contained!
2%!monocytes!among!all!other!leukocytes,!further!confirming!successful!extraction!of!








6.10A).!Of! the!purified! total!monocyte!population,!classical!monocytes! represented!





































































































































































































































































using!Lysing!Buffer! (BD!Pharm!Lyse,!#555899).!PBMCs!were! then!subject! to!monocyte!negative! selection!using! the!Monocyte!










































































































































































































6.2.7% FACS% Analysis% of% NF!B% subunit% p65% Phosphorylation% by% CX3CL1%
stimulation%of%Monocytes%%
!
The! purification! of!monocytes! from! human!whole! blood! described! in! the! previous!
section!was!performed!to!establish!the!counts!of!monocytes!that!could!be!obtained!
from! a! specified! volume! of! blood! and! thus! determine! the! sample! required! for!
subsequent! protein! and! gene! expression! experiment! analysis.! It! was! initially!
hypothesized!that!the!CX3CR1+!nonEclassical!monocyte!proportion!of!this!purified!total!
monocyte!population!would!show!a!stronger!NF!B!response!to!CX3CL1!stimulation!
than! that! observed! for! THPE1!monocytes,! due! to! their! higher! expression! levels! of!
CX3CR1! (Figure!6.10A).!However,! the!yield!of!nonEclassical!monocytes! that! could!
theoretically!be!obtained!(2.15x104E4.3x104!/!ml!blood),!would!not!permit!the!study!of!













treatment,! it! was! observed! that! all! monocytes! were! no! longer! viable! leading! to!
termination!of!the!experiment.!This!is!likely!due!to!the!effect!of!serumEstarvation!which!
has! been! shown! to! induce! apoptosis! of! monocytes.! CX3CL1! has! been! shown! to!
rescue!cells!from!starvationEinduced!apoptosis,!though!interestingly!there!was!no!proE
survival! effect! observed! in! CX3CL1Etreated! cells! during! this! experiment.! Other!










CD14+CD16++CX3CR1hiCCR2lo! cells.! This! technique! required! optimisation,! as! a!











showed! that!untreated!MM6!cells!showed!slight! induction!of! the!NF!B!pathway!as!
determined! by! increased! levels! of! pEp65! (Figure! 6.11,! 6.12),! which! reflected! the!








monocytes,! this! protocol! was! decided! to! be! performed! on! human! whole! blood!
samples,! which! would! permit! examination! of! the! specific! CX3CR1hi! nonEclassical!
monocyte!NF!B!response! to!CX3CL1,!by!gating!on!CD14+CD16++!cells.!This!work!









































































































































































































































































































































































































































































































Untreated! cells! showed! low! levels! of! pEp65!which! are! comparable! with! the! levels!
observed!following!treatment!with!CX3CL1!at!10ng/ml!for!60!min.!This!response!is!not!
blocked!in!the!presence!of!the!CX3CR1!inhibitor!KAN567,!suggesting!induction!of!the!



























































































CX3CL1 activation of NFκB 








downstream! proEinflammatory! NF!B! signalling! cascade.! Elucidation! of! the!
mechanisms!of!CX3CL1/CX3CR1!signalling! in!nonEclassical!monocytes!will!help! to!
explain!their!exact!function!following!cardiac!I/R,!and!therefore!help!to!understand!the!
mechanistic! link! between! their! dynamics! in! the! circulation!and!myocardial! function!
following!STEMI.!
!
The! data! presented! in! this! chapter! indicates! that! CX3CL1! treatment! of! THPE1!
monocytes!at!the!optimal!time!and!dose!(10ng/ml!for!60!minutes)!can!induce!modest!





form! of! p65! induces! ILE8! transcription,! while! the! S536A! form,! which! cannot! be!
phosphorylated!at!the!p65ESer536!site,!does!not![405].!As!previously!mentioned,!the!




that! stimulation! of! human! CX3CR1hi! nonEclassical! monocytes! by! CX3CL1! would!
induce! stronger! activation! of! the! NF!B! pathway! due! to! the! considerably! higher!
expression!of!CX3CR1!by! this!monocyte!subset.! Investigation!of! this!nonEclassical!
monocyte!NF!B!response!to!CX3CL1!stimulation!is!however!restricted!to!the!use!of!
freshly!isolated!human!nonEclassical!monocytes,!due!to!the!lack!of!an!established!nonE








Activation! of! NF!B! pathway! by! CX3CL1! stimulation! specifically! in! nonEclassical!
monocytes!can!then!be!achieved!by!FACS!analysis!of!pEp65.!In!this!thesis,!I!present!




While! it! is! possible! that! the!minimal! response! of! THPE1!monocytes! to!CX3CL1! is!
related! to! low!CX3CR1!expression,! another! consideration! to!make! is! the! effect! of!
serum!on! the!activation!of! the!NF!B!signalling! cascade.! It! is!well! established! that!
activation!of!this!pathway!can!be!induced!by!a!broad!range!of!stimuli,!each!of!which!
mediates! a! specific! pathway! of! NF!B! activation! to! induce! a! specific! downstream!
function.!A!number!of!reports!have!suggested!that!exposure!of!cells!to!fresh!media!
influences! NF!B! activation! [407]! and! target! gene! expression.! To! avoid! the!
confounding! effects! of! serum! on! NF!B! activation! in! this! study,! THPE1! cells! were!







however! this! starvation! of! cells! would! also! introduce! confounding! factorse! serum!




human! primary! cells! also! identified! substantial! constitutive! NF!B! activity! in! blood!
monocytes.!It!is!therefore!arguable!that!treatment!of!THPE1!cells!with!fresh!media!48h!












not! repress! the! ILE8! promoter.! [369].! As! such,! it! is! possible! that! induction! of! ILE8!
expression!in!monocytes!may!still!occur!during!inhibition!of!the!NF!B!pathway.!Future!







A! reproducible!effect!of!CX3CL1!on!NF!BEmediated! ILE8!expression!would!help! to!
explain!the!function!of!CX3CR1!monocytes!following!cardiac!I/R,!since!ILE8!is!heavily!
implicated! in! cardiovascular! disease! [409].! Following! ! MI,! ILE8! induces! homing! of!
neutrophils! that! contribute! to! myocardial! injury! [410].! It! could! therefore! be!
hypothesized!that!increased!CX3CL1!ligand!in!the!circulation!following!STEMI!induces!
NF!B! activation! in! the! vascular! pool! of! CX3CR1+! nonEclassical!monocytes,! which!
leads! to! increased! production! of! ILE8! and! therefore! potentiated! proEinflammatory!
neutrophil!recruitment!to!the!infarct.!Future!experiments!should!therefore!examine!ILE









cause! rolling!monocytes! to! firmly!adhere! to!endothelialEexpressed!EEselectin! [412].!




[413].! Furthermore! in! STEMI! patients,! high! circulating! concentrations! of! ILE8! is!




therefore! result! in! different! effects! on! the! immune! response! to! cardiac! I/R.! Since!
CX3CL1!is!known!to!peak!at!90!minutes!following!reperfusion!in!STEMI!patients![209],!
CX3CL1!may! induce! the! greatest! expression! of! ILE8! at! this! time! point,! leading! to!
increased!production!of!ILE8!6h!following!stimulation,!as!shown!in!this!study.!This!may!
lead!to!increased!adhesion!of!nonEclassical!monocytes!to!the!endothelium,!or!cause!























axis! in! this! response.! To! date,! research! has! documented! the! CX3CR1Emediated!
patrolling!function!of!these!cells!along!the!vascular!endothelium!in!both!human!and!
mouse,!though!their!function!outside!of!this!immune!surveillance!in!the!acute!response!
to! cardiac! I/R! is! unknown.! In! mouse! models! of! cardiac! I/R,! Ly6Clo! nonEclassical!
monocytes!are!known!to!dominate!the!second,!reparative!phase!of!repair!at!day!5E9!
postEMI.!These!cells!largely!arise!from!the!maturation!of!Ly6Chi!classical!monocytes!
which! mediate! the! inflammatory! phase! of! repair! (day! 1E3! postEMI).! Recent! work!
however!suggests!an!earlier!role!of!CX3CR1+!nonEclassical!monocytes,!specifically!of!
the!‘patrolling!vascular!pool’!of!these!cells,!which!have!been!observed!in!the!injured!
myocardium! within! the! first! 3h! of! reperfusion! [161,! 163].! This! thesis! therefore!








analysis!of!nonEclassical!monocyte!dynamics! in! the!circulation!at!acute! time!points!
after!reperfusion!(15min,!30min,!90min,!180min,!24h).!!This!study!presents!a!novel!
analysis!as! there!has!been!no!previous! investigation!of!monocyte!dynamics!during!
this! immediate! postEreperfusion! period! among! published! studies! to! date.! The!
prospective!study!described!in!chapter!4!also!provides!a!highly!accurate!quantification!







The! prevailing! result! from! these! studies! was! that! nonEclassical! monocytes! are!














MVO,! this! study! suggests! that! monocyte! kinetics! during! the! acute! 24h! postE
reperfusion!are!more!related!to!infarct!size!than!to!microvascular!damage.!This!is!in!




The!nature!of! this! relationship! is!unclear,!however!a!possible!mechanism! is! that!a!














much! larger! cohort! of! STEMI! patients,! and! validate! the! findings! presented! in! this!
thesis.!!
!
7.1.3% Genetic% knockout% of% CX3CR1% affects% the% counts% of% circulating% nonG
classical%monocytes,%but%not% their% infiltration% into% the% injured%myocardium%or%
cardiac%function%following%myocardial%I/R.%
!
A! large! proportion! of! this! thesis! is! focused! on! a! murine! model! of! cardiac! I/R! to!
investigate! the! effect! of! genetic! CX3CR1! knockout! on! the! monocyte! response! to!
myocardial!I/R.!This!model!provided!two!main!powerful!tools!that!were!unavailable!in!
the!clinical!settinge!direct!access! to! injured!heart! tissue,!and!a!model!of!CX3CR1E/E!
monocytes,! using! the! CX3CR1EGFP! mouse! line.! To! draw! comparisons! with! the!
observed!STEMI! patient! depletion! of! circulating! nonEclassical!monocytes! following!
reperfusion,! mouse! circulating! monocyte! subpopulations! were! quantified! at! 2h!
following!induced!cardiac!I/R.!Mouse!Ly6Clo!nonEclassical!monocytes!were!depleted!
in!the!circulation,!as!observed!in!the!clinical!setting.!This!however!was!not!confined!to!
nonEclassical! monocytes! but! was! also! observed! for! classical! and! intermediate!
populations,!which!may!relate! to! the!similar!expression! levels!of!CX3CR1!between!
subsets,!as!discussed!in!Chapter!5.!When!analyzing!the!effect!of!CX3CR1!knockout!














and! 24h.! Based! on! the! data! presented! here,! genetic!CX3CR1! knockout! does! not!
significantly!affect!the!infiltration!of!total!monocytes!into!the!injured!myocardium!at!2h,!
24h,!or!day!3!following!cardiac!I/R.!SubEclassification!of!monocytes!into!classical!and!













future! work! is! required! to! investigate! monocyte! behaviour! in! wildEtype! mice.! The!
methodological! limitations! regarding! monocyte! subset! definition! by!
immunofluorescence! microscopy! in! this! study! also! require! these! findings! to! be!
confirmed!using!more!robust!methods!of!nonEclassical!monocyte!definition!in!the!heart!
tissue! such! as! timeElapse! imaging,! intraEvital! microscopy,! or! confocal! microscopy.!
Future!work!should!also!build!on!the!existing!findings!from!this! thesis!showing!that!
mouse!circulating!nonEclassical!monocytes!express!significantly!greater!levels!of!PDE











knockout! hearts! showed! no! effect! of! CX3CR1! knockout! on! macrophage!
subpopulations!at!day!3.!A!lack!of!phenotype!was!also!observed!in!the!assessment!of!
mouse! myocardial! function! at! 6! weeks! following! cardiac! I/R! by! MRIe! wildEtype,!
Cx3cr1+/GFP!and!CX3CR1!knockout!mice!showed!no!significant!differences! in!ESV,!
EDV,!and!LVEF!parameters.!As!discussed! in!detail! in!chapter!5,! the!absence!of!a!
striking! phenotype! in! CX3CR1E/E! mice! may! be! explained! by! the! development! of!
compensatory!mechanisms!to!overcome!the!lack!of!this!key!receptor.!Investigation!of!
CX3CL1/CX3CR1! inhibition! through! other! mechanism! such! as! pharmacological!
inhibition!of!CX3CR1!or!CX3CL1,!which!would!not!be!confounded!by!compensatory!
mechanisms,!should!therefore!be!investigated!in!future!research.!Other!studies!have!







The! third! aim! of! this! project! was! to! investigate! activation! of! the! NF!B! pathway!
downstream!of!CX3CL1/CX3CR1!stimulation! in!human!monocytes.!Both! the!NF!B!
pathway! and! the! CX3CL1/CX3CR1! axis! have! been! implicated! in! the! extent! of!
myocardial!damage!following!cardiac!I/R,!therefore!it!was!hypothesized!that!CX3CL1!
stimulation! of! nonEclassical! monocyteEexpressed! CX3CR1! activates! downstream!
NF!B!signalling,! leading! to!upregulated!proEinflammatory! functions!of!nonEclassical!
monocytes.!Immunophenotyping!of!human!monocyte!cell!lines!THPE1,!MM6!and!U937!
cells! demonstrated! that! all! three! cell! lines! resembled! human! circulating! classical!
monocytes! in! terms!of!CX3CR1,!CD16,!and!CD14!expression.!Following! time!and!
doseEresponse!optimisation!of!CX3CL1!stimulation,!I!showed!that!THPE1!monocytes!
show!modest!activation!of!the!NF!B!subunit!p65!in!response!to!CX3CL1!treatment!
(10ng/ml! 60! minutes).! Under! these! optimised! conditions,! THPE1! monocytes! also!
showed!modest! but! significant! upregulation! of! the! proEinflammatory! cytokine! ILE8.!
Since!ILE8!is!an!established!chemotactic!factor!for!neutrophil!recruitment!to!injured!or!





may! lead! to!activation!of! the!NF!B!cascade!and!upregulated!production!of! ILE8!by!






may!be! reflective!of! the! low!expression!of!CX3CR1!by!THPE1!monocytes.!Such!a!
response! may! be! greater! in! nonEclassical! monocytes! which! express! considerably!
higher! levels! of! CX3CR1.! Since! there! is! no! existing! cell! line! that! represents! nonE
classical!monocytes,! these!cells!must!be! isolated! from!human!whole!blood.! In! this!
thesis!I!validated!a!method!of!purifying!total!monocytes!from!human!whole!peripheral!
blood! using! negative! selection! beads,! which! yielded! a! high! purity! (>95%)! of!
monocytes.!While!this!method!achieved!a!high!purity!of!total!monocytes,!culturing!of!





classical! monocyte! pEp65! expression! could! be! distinguished! from! that! of! other!
monocyte! subsets! by! gating! on!CD14+CD16++! cells! during! FACS! analysis.! Future!
work! should! therefore! utilise! this! optimised!protocol! to! investigate!NF!B!activation!
specifically! in! human! CX3CR1hi! nonEclassical! monocytes! in! response! to! CX3CL1!
stimulation.!Identification!of!a!heightened!NF!B!response!in!these!cells!compared!to!
MM6!classicalElike!monocytes!would!suggest!CX3CL1Especific!induction!of!the!NFkB!
pathway.!Another!approach! to! investigate! this! in! future!work!would!be! to! transfect!

















































































be! present! in! the! infarct! as! early! as! 15m! following! reperfusion!may! be! derived! from!a! vascular! pool! of! patrolling! nonFclassical!













as! creatine! kinase! and! troponins.! Other! studies! investigating! a! mouse! model! of!
cardiac!I/R!indeed!have!utilized!these!measuresE!24h!after! induction!of!MI,!a!blood!
sample!is!collected!from!the!tail!vein!into!a!tube!containing!sodium!citrate!buffer!for!
assay! of! troponin! I! by! ELISA! (Life! Diagnostics! High! Sensitivity! Mouse! Cardiac!
TroponinPI!ELISA!kit)!to!assess!the!extent!of!ischemic!injury![415,!416].!Cardiovascular!







When! investigating! monocytes! in! the! mouse! spleen! and! bone! marrow! following!
cardiac! I/R,! inadequate! number! of! animals! in! certain! groups! prevented! statistical!
















to! the! traditional! nomenclature! that! classical! monocytes! are! CX3CR1lo! and! nonP
classical!monocytes!CX3CR1hi.!However!more!recent!studies!have!now!shown!that!
eGFP! expression! does! not! correlate! with! CX3CR1! surface! protein! expression! on!
classical!and!nonPclassical!monocytes.!A!recent!study!has!shown!that!eGFP!level!in!
Cx3cr1+/GFP! mice! does! not! reflect! CX3CR1! expression! (as! measured! using! antiP
CX3CR1! antibody)! [419],! and! consequently! CX3CR1! expression! does! not!
discriminate!mouse!classical!monocytes!from!nonPclassical!monocytes!using!a!multiP
parametric! analysis! of! mouse! blood! monocytes! in! steady! state! or! inflammatory!
conditions!(measured!by!either!antiPCX3CR1!antibody!or!CX3CL1PAF647!uptake).!As!
such,! the! cytosolic! reporter! eGFP! is! an! indirect! measure! of! CX3CR1! surface!
expression,! and! the! previous! definition! of! CX3CR1lo! classical! monocytes! and!




subsets,! unlike! CX3CR1E! in! the! blood,! bone! marrow,! spleen,! and! lung,! classical!
monocytes!are!Ly6Chi!CD43P/lo,!while!nonPclassical!monocytes!are!Ly6Clo!CD43hi.!
!
Another! recent! study! showed! that! CX3CR1! mRNA! and! protein! expression! is! not!
significantly!different!between!mouse!classical!and!nonPclassical!monocytes,!however!
is!significantly!increased!on!nonPclassical!monocytes!in!the!bone!marrow,!indicating!a!
loss!of! this! receptor!expression!on!nonPclassical!monocytes! in! the!blood! [420].!By!
contrast! in! humans,! CX3CR1! expression! is! significantly! greater! on! nonPclassical!
monocytes!than!classical!monocytes!in!the!blood,!bone!marrow,!spleen,!and!lung,!and!










The! research! presented! in! this! thesis! builds! on! recent! findings! demonstrating! an!
earlier!role!of!nonPclassical!monocytes!following!cardiac!I/R!than!originally!believed.!
STEMI! patient! nonPclassical! monocyte! dynamics! immediately! following! PCI! are!
associated! with!myocardial! function,! suggesting! a!mechanistic! link! between! these!
cells!and!cardiac!repair!while!also!offering!a!potential!biomarker!to!stratify!patients.!







role.! These! findings! are! of! significant! clinical! relevance,! as! there! is! currently! no!
approved! therapeutic! treatment! for! ischaemia! reperfusion! injury! in!STEMI! patients!
following!PCI!to! improve!outcomeE!currently!approved!therapeutics!are!restricted!to!
antiPclotting!strategies,!which!do!not! target! ischemia! reperfusion! injury.!Harnessing!
the!CX3CL1/CX3CR1Pmediated!nonPclassical!monocyte!response!in!the!acute!postP
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